


Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft










      
  
    Buy Hand Conduit Benders and Handles | Zoro.com
  

    
LAWN AND OUTDOOR SALE•20% OFF 5 CATEGORIES•Enter Code: LAWNGEAR•JULY 25-31•SEE DETAILS AND CATEGORIESEnter Search TermWelcomeMy AccountSign OutSign In/Register...Cart
          
            Shop Categories
          
        
                Safety & SecuritySafety & Security
                      Fall Protection, Facility & Traffic  Safety Equipment 
                    
                      Gloves, Eyewear, Ear Protection, Masks & Clothing
                    
                      Padlocks, Lockout/Tagout & Security Equipment
                    
                      Signs & Labels
                    
                      Test Instruments & Gauges
                    
                Tools & MachiningTools & Machining
                      Abrasives & Polishers
                    
                      Cutting, Holemaking & Shaping Tools
                    
                      Hand Tools
                    
                      Knobs, Handles, Workholding & Machine Tool Accessories
                    
                      Power Tools and Accessories
                    
                      Raw Materials
                    
                Plumbing & HVACPlumbing & HVAC
                      Fans & HVAC Equipment
                    
                      Pipes, Valves & Fittings
                    
                      Toilets, Sinks, Faucets & Plumbing Supplies
                    
                Material HandlingMaterial Handling
                      Carts, Trucks & Casters
                    
                      Drum & Dock Equipment
                    
                      Material Handling Equipment (Pulling, Lifting, Lowering, Conveying)
                    
                      Storage, Shelving, Ladders & Lifts
                    
                Electrical & LightingElectrical & Lighting
                      Electrical Supplies & Generators
                    
                      Lighting, Flashlights & Batteries
                    
                Adhesives, Fasteners, & WeldingAdhesives, Fasteners, & Welding
                      Adhesives & Sealants
                    
                      Fasteners
                    
                      Tapes (Electrical, Duct, Painters)
                    
                      Welding & Soldering Equipment & Supplies
                    
                Janitorial & Grounds MaintenanceJanitorial & Grounds Maintenance
                      Door and Cabinet Hinges & Hardware
                    
                      Grounds Maintenance & Outdoor Equipment
                    
                      Janitorial & Cleaning Supplies
                    
                      Paint, Coatings & Supplies
                    
                Power Transmission & PneumaticsPower Transmission & Pneumatics
                      Auto & Truck Maintenance
                    
                      Bearings, V-belts & Power Transmission Equipment
                    
                      Compressors, Air Tanks & Pneumatic Tools 
                    
                      Fluids & Lubricants
                    
                      Hydraulic Cylinders & Equipment
                    
                      Motors
                    
                Office & ShippingOffice & Shipping
                      Office Supplies, Furniture & Breakroom Supplies
                    
                      Shipping & Packing Supplies
                    About UsPayment OptionsResourcesPromo CodesContact UsShop CategoriesAdhesives, Fasteners, & WeldingElectrical & LightingJanitorial & Grounds MaintenanceMaterial HandlingOffice & ShippingPlumbing & HVACPower Transmission & PneumaticsSafety & SecurityTools & MachiningAbout UsPayment OptionsResourcesPromo CodesContact UsMy AccountSign OutSign In/RegisterHomeHand ToolsBendersHand Conduit Benders and Handles
            Browse Categories
            Filter by
                Brands
                
                Price
                
          See 4 More Filters
        
    featured
  Offset Bender For 3/4 EmtGREENLEE|Zoro #: G0579078 |
    Mfr #: 14159
  Item: Offset Bender For 3/4 Emt
    View Full Product Details
    
  
    
      This item ships free. DetailsStandard ground shipping$373.78/eaqtyAdd to CartShowing 
      1 - 30 of 68
      results
    
  Sort by: RelevancePrice: Low to High
        Price: High to Low
        Product Name: A-Z
        Product Name: Z-A
        Brand: A-Z
        Brand: Z-A
        Previous123Next123Shipping InformationA $5.00 shipping and handling fee is charged on orders totaling less than
        $50.00
        before tax and shipped to one address within the continental United States.No shipping and handling is charged to customers for standard ground delivery on orders of
        $50.00
        or more before tax.Shipping Policy Exceptions:Not all products qualify for the above Shipping Policy. Additionally, standard shipping rates will apply for all orders to Alaska and Hawaii.Any charges incurred for hazardous materials or other special handling by the carrier must be paid by the customer.Fuel surcharges may be applied.Zoro only accepts orders for shipments within the continental US, Alaska and Hawaii.Orders to international destinations will not be processed.Zoro does not ship to PO Box addresses.UPS is our primary parcel carrier and we use a variety of carriers for LTL shipments.Expedited Shipping Rules:To qualify for expedited shipping Zoro must receive your order before 3:00PM CST Monday–Friday; all orders must weigh less than 150 lbs, and not contain any hazardous materials.Expedited orders only ship on business days; any orders placed on Satudays/Sundays/Holidays will be processed on the next business day.If you have any questions please call our customer service department at 855‑BUY-ZORO (855-289-9676).In Stock
  Item ships from Zoro warehouses and will ship within 1 business day. Standard delivery time is 3-5 business days.
  You will be provided tracking via email as soon as your order ships.
Orders that qualify for expedited shipping must be placed by 3pm CST to ship same day.Limited Stock
  This item has low stock in our warehouses and your order will ship based on availability. If an item cannot be fulfilled immediately it will be ordered from our manufacturer.
Orders that qualify for expedited shipping must be placed by 3pm CST to ship same day.Backordered
  Item is not currently in stock and will be ordered from manufacturer to fulfill your order.
  As soon as your order ships you will receive tracking information via email.
Drop ship
  Item will ship from manufacturer within the lead time specified on this page.


      Zoro.com: Industrial Supplies, Tools, MRO Products & More
    
LAWN AND OUTDOOR SALE•20% OFF 5 CATEGORIES•Enter Code: LAWNGEAR•JULY 25-31•SEE DETAILS AND CATEGORIESEnter Search TermWelcomeMy AccountSign OutSign In/Register...Cart
          
            Shop Categories
          
        
                Safety & SecuritySafety & Security
                      Fall Protection, Facility & Traffic  Safety Equipment 
                    
                      Gloves, Eyewear, Ear Protection, Masks & Clothing
                    
                      Padlocks, Lockout/Tagout & Security Equipment
                    
                      Signs & Labels
                    
                      Test Instruments & Gauges
                    
                Tools & MachiningTools & Machining
                      Abrasives & Polishers
                    
                      Cutting, Holemaking & Shaping Tools
                    
                      Hand Tools
                    
                      Knobs, Handles, Workholding & Machine Tool Accessories
                    
                      Power Tools and Accessories
                    
                      Raw Materials
                    
                Plumbing & HVACPlumbing & HVAC
                      Fans & HVAC Equipment
                    
                      Pipes, Valves & Fittings
                    
                      Toilets, Sinks, Faucets & Plumbing Supplies
                    
                Material HandlingMaterial Handling
                      Carts, Trucks & Casters
                    
                      Drum & Dock Equipment
                    
                      Material Handling Equipment (Pulling, Lifting, Lowering, Conveying)
                    
                      Storage, Shelving, Ladders & Lifts
                    
                Electrical & LightingElectrical & Lighting
                      Electrical Supplies & Generators
                    
                      Lighting, Flashlights & Batteries
                    
                Adhesives, Fasteners, & WeldingAdhesives, Fasteners, & Welding
                      Adhesives & Sealants
                    
                      Fasteners
                    
                      Tapes (Electrical, Duct, Painters)
                    
                      Welding & Soldering Equipment & Supplies
                    
                Janitorial & Grounds MaintenanceJanitorial & Grounds Maintenance
                      Door and Cabinet Hinges & Hardware
                    
                      Grounds Maintenance & Outdoor Equipment
                    
                      Janitorial & Cleaning Supplies
                    
                      Paint, Coatings & Supplies
                    
                Power Transmission & PneumaticsPower Transmission & Pneumatics
                      Auto & Truck Maintenance
                    
                      Bearings, V-belts & Power Transmission Equipment
                    
                      Compressors, Air Tanks & Pneumatic Tools 
                    
                      Fluids & Lubricants
                    
                      Hydraulic Cylinders & Equipment
                    
                      Motors
                    
                Office & ShippingOffice & Shipping
                      Office Supplies, Furniture & Breakroom Supplies
                    
                      Shipping & Packing Supplies
                    About UsPayment OptionsResourcesPromo CodesContact UsShop CategoriesAdhesives, Fasteners, & WeldingElectrical & LightingJanitorial & Grounds MaintenanceMaterial HandlingOffice & ShippingPlumbing & HVACPower Transmission & PneumaticsSafety & SecurityTools & MachiningAbout UsPayment OptionsResourcesPromo CodesContact UsMy AccountSign OutSign In/RegisterSafety & SecurityTools & MachiningPlumbing & HVACMaterial HandlingElectrical & LightingAdhesives, Fasteners & WeldingJanitorial & Grounds MaintenancePower Transmission & PneumaticsOffice & ShippingLearn more about Zoro

      Contact Us
    
LAWN AND OUTDOOR SALE•20% OFF 5 CATEGORIES•Enter Code: LAWNGEAR•JULY 25-31•SEE DETAILS AND CATEGORIESEnter Search TermWelcomeMy AccountSign OutSign In/Register...Cart
          
            Shop Categories
          
        
                Safety & SecuritySafety & Security
                      Fall Protection, Facility & Traffic  Safety Equipment 
                    
                      Gloves, Eyewear, Ear Protection, Masks & Clothing
                    
                      Padlocks, Lockout/Tagout & Security Equipment
                    
                      Signs & Labels
                    
                      Test Instruments & Gauges
                    
                Tools & MachiningTools & Machining
                      Abrasives & Polishers
                    
                      Cutting, Holemaking & Shaping Tools
                    
                      Hand Tools
                    
                      Knobs, Handles, Workholding & Machine Tool Accessories
                    
                      Power Tools and Accessories
                    
                      Raw Materials
                    
                Plumbing & HVACPlumbing & HVAC
                      Fans & HVAC Equipment
                    
                      Pipes, Valves & Fittings
                    
                      Toilets, Sinks, Faucets & Plumbing Supplies
                    
                Material HandlingMaterial Handling
                      Carts, Trucks & Casters
                    
                      Drum & Dock Equipment
                    
                      Material Handling Equipment (Pulling, Lifting, Lowering, Conveying)
                    
                      Storage, Shelving, Ladders & Lifts
                    
                Electrical & LightingElectrical & Lighting
                      Electrical Supplies & Generators
                    
                      Lighting, Flashlights & Batteries
                    
                Adhesives, Fasteners, & WeldingAdhesives, Fasteners, & Welding
                      Adhesives & Sealants
                    
                      Fasteners
                    
                      Tapes (Electrical, Duct, Painters)
                    
                      Welding & Soldering Equipment & Supplies
                    
                Janitorial & Grounds MaintenanceJanitorial & Grounds Maintenance
                      Door and Cabinet Hinges & Hardware
                    
                      Grounds Maintenance & Outdoor Equipment
                    
                      Janitorial & Cleaning Supplies
                    
                      Paint, Coatings & Supplies
                    
                Power Transmission & PneumaticsPower Transmission & Pneumatics
                      Auto & Truck Maintenance
                    
                      Bearings, V-belts & Power Transmission Equipment
                    
                      Compressors, Air Tanks & Pneumatic Tools 
                    
                      Fluids & Lubricants
                    
                      Hydraulic Cylinders & Equipment
                    
                      Motors
                    
                Office & ShippingOffice & Shipping
                      Office Supplies, Furniture & Breakroom Supplies
                    
                      Shipping & Packing Supplies
                    About UsPayment OptionsResourcesPromo CodesContact UsShop CategoriesAdhesives, Fasteners, & WeldingElectrical & LightingJanitorial & Grounds MaintenanceMaterial HandlingOffice & ShippingPlumbing & HVACPower Transmission & PneumaticsSafety & SecurityTools & MachiningAbout UsPayment OptionsResourcesPromo CodesContact UsMy AccountSign OutSign In/RegisterContact usWe’re happy to answer your questions. We respond to most inquiries within 24 hours.Contact usWe’re happy to answer your questions. We respond to most inquiries within 24 hours.We’re not satisfied until you areMost of our business happens right here on Zoro.com. But, we know sometimes you just need to talk to a real person. Whether you want to call us or email us, our customer service staff is available Monday through Friday from 6 a.m. to 9 p.m. (CST) and Saturdays from 7 a.m. to 5 p.m. (CST).Si necesita ayuda en español, por favor, comuníquese con nosotros por teléfono. Gracias.Phone 855.BUY.ZORO (855.289.9676)Fax 855.FAX.ZORO (855.329.9676)



Insider Trading - 14159 L.P. - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - 14159 L.P.





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In


Goto page 0,
1,
Next
Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-11-18Purchase
2016-11-216:13 pm
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
1,760,495
$32
$56,335,840
73,162,024(Indirect)
View


2016-10-07Purchase
2016-10-115:45 pm
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
3,250,000
$2
$6,500,000
9,309,333(Indirect)
View


2016-08-15Purchase
2016-08-156:02 pm
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
100,000
$27.02
$2,701,590
11,348,958(Indirect)
View


2016-08-10Purchase
2016-08-124:08 pm
Acadia Pharmaceuticals Inc
ACAD
Baker BROS. Advisors LpBaker Brothers Life Sciences LpBaker Bros. Advisors (gp) LLCBaker FelixBaker Julian667 L.P.14159 L.P.Director10% Owner
1,303,030
$33
$42,999,990
22,337,276(Indirect)
View


2016-03-30Purchase
2016-04-014:21 pm
Acadia Pharmaceuticals Inc
ACAD
Baker BROS. Advisors LpBaker FelixBaker Julian667 L.P.14159 L.P.Baker Brothers Life Sciences LpBaker Bros. Advisors (gp) LLCDirector10% Owner
1,449,090
$27.08
$39,239,808
21,167,398(Indirect)
View


2016-03-15Purchase
2016-03-177:14 pm
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
800,000
$63.98
$51,184,193
19,757,284(DirectIndirect)
View


2016-02-24Purchase
2016-02-264:42 pm
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
64,290
$70.79
$4,550,987
19,015,852(DirectIndirect)
View


2016-02-12Purchase
2016-02-168:14 pm
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
887,165
$69.87
$61,983,800
18,958,070(DirectIndirect)
View


2016-02-11Purchase
2016-02-168:13 pm
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
2,251,427
$63.53
$143,029,696
18,158,080(DirectIndirect)
View


2016-02-08Purchase
2016-02-095:38 pm
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
1,912,680
$24
$45,904,320
73,162,024(Indirect)
View


2016-01-07Purchase(A)
2016-01-087:07 pm
Acadia Pharmaceuticals Inc
ACAD
Baker BROS. Advisors LpBaker FelixBaker Julian667 L.P.14159 L.P.Baker Brothers Life Sciences LpBaker Bros. Advisors (gp) LLCDirector10% Owner
2,586,206
$29
$74,999,974
20,278,008(Indirect)
View


2016-01-07Purchase
2016-01-086:07 pm
Acadia Pharmaceuticals Inc
ACAD
14159 L.P.667 L.P.Baker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences LpBaker FelixBaker JulianDirector10% Owner
2,586,206
$29
$74,999,974
20,278,008(Indirect)
View


2015-07-22Sale
2015-07-235:35 pm
Xoma Corp
XOMA
Baker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCBaker FelixBaker JulianOther
11,000,000
$1.092
$12,017,500
3,153,539(Indirect)
View




 (A) Indicate amendment filing.
 Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2017-01-03Option Award
2017-01-057:00 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
14,169
$1.5
9,323,502(Indirect)
View


2017-01-03Option Award
2017-01-057:00 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
14,169
$1.5
9,323,502(Indirect)
View


2017-01-03Option Award
2017-01-057:00 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
14,169
$1.5
9,323,502(Indirect)
View


2017-01-01Option Award
2017-01-046:30 pm
N/AN/A
Genomic Health Inc
GHDX
Baker Felix14159 L.P.667 L.P.Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Bros. Investments II L.P.Baker Bros. Investments L.P.Baker Brothers Life Sciences LpBaker/tisch Investments LpDirector10% Owner
680
$29.39
11,350,328(Indirect)
View


2017-01-01Option Award
2017-01-046:30 pm
N/AN/A
Genomic Health Inc
GHDX
Baker Felix14159 L.P.667 L.P.Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Bros. Investments II L.P.Baker Bros. Investments L.P.Baker Brothers Life Sciences LpBaker/tisch Investments LpDirector10% Owner
680
$29.39
11,350,328(Indirect)
View


2017-01-01Option Award
2017-01-046:30 pm
N/AN/A
Genomic Health Inc
GHDX
Baker Felix14159 L.P.667 L.P.Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Bros. Investments II L.P.Baker Bros. Investments L.P.Baker Brothers Life Sciences LpBaker/tisch Investments LpDirector10% Owner
680
$29.39
11,350,328(Indirect)
View


2017-01-01Option Award
2017-01-046:30 pm
N/AN/A
Genomic Health Inc
GHDX
Baker Felix14159 L.P.667 L.P.Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Bros. Investments II L.P.Baker Bros. Investments L.P.Baker Brothers Life Sciences LpBaker/tisch Investments LpDirector10% Owner
680
$29.39
11,350,328(Indirect)
View


2017-01-01Option Award
2017-01-046:30 pm
N/AN/A
Genomic Health Inc
GHDX
Baker Felix14159 L.P.667 L.P.Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Bros. Investments II L.P.Baker Bros. Investments L.P.Baker Brothers Life Sciences LpBaker/tisch Investments LpDirector10% Owner
680
$29.39
11,350,328(Indirect)
View


2017-01-01Option Award
2017-01-046:30 pm
N/AN/A
Genomic Health Inc
GHDX
Baker Felix14159 L.P.667 L.P.Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Bros. Investments II L.P.Baker Bros. Investments L.P.Baker Brothers Life Sciences LpBaker/tisch Investments LpDirector10% Owner
680
$29.39
11,350,328(Indirect)
View


2016-12-30Option Award
2017-01-046:01 pm
N/AN/A
Incyte Corp
INCY
Baker Julian14159 L.P.667 L.P.Baker FelixBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences LpDirector10% Owner
189
$100.3
19,758,174(Indirect)
View


2016-12-30Option Award
2017-01-046:01 pm
N/AN/A
Incyte Corp
INCY
Baker Julian14159 L.P.667 L.P.Baker FelixBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences LpDirector10% Owner
189
$100.3
19,758,174(Indirect)
View


2016-12-30Option Award
2017-01-046:01 pm
N/AN/A
Incyte Corp
INCY
Baker Julian14159 L.P.667 L.P.Baker FelixBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences LpDirector10% Owner
189
$100.3
19,758,174(Indirect)
View


2016-10-03Option Award
2016-10-054:30 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
8,299
$2.56
6,380,737(Indirect)
View


2016-10-03Option Award
2016-10-054:30 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
8,299
$2.56
6,380,737(Indirect)
View


2016-10-03Option Award
2016-10-054:30 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
8,299
$2.56
6,380,737(Indirect)
View


2016-09-30Option Award
2016-10-046:35 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
690
$28.92
11,349,648(Indirect)
View


2016-09-30Option Award
2016-10-046:35 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
690
$28.92
11,349,648(Indirect)
View


2016-09-30Option Award
2016-10-046:35 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
690
$28.92
11,349,648(Indirect)
View


2016-09-30Option Award
2016-10-046:35 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
690
$28.92
11,349,648(Indirect)
View


2016-09-30Option Award
2016-10-046:35 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
690
$28.92
11,349,648(Indirect)
View


2016-09-30Option Award
2016-10-046:35 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
690
$28.92
11,349,648(Indirect)
View


2016-09-30Option Award
2016-10-046:33 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
201
$94.29
19,757,984(Indirect)
View


2016-09-30Option Award
2016-10-046:33 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
201
$94.29
19,757,984(Indirect)
View


2016-09-30Option Award
2016-10-046:33 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
201
$94.29
19,757,984(Indirect)
View


2016-07-01Option Award
2016-07-066:22 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
746
$26.74
11,259,062(Indirect)
View


2016-07-01Option Award
2016-07-066:22 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
746
$26.74
11,259,062(Indirect)
View


2016-07-01Option Award
2016-07-066:22 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
746
$26.74
11,259,062(Indirect)
View


2016-07-01Option Award
2016-07-066:22 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
746
$26.74
11,259,062(Indirect)
View


2016-07-01Option Award
2016-07-066:22 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
746
$26.74
11,259,062(Indirect)
View


2016-07-01Option Award
2016-07-066:22 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Director10% Owner
746
$26.74
11,259,062(Indirect)
View


2016-07-01Option Award
2016-07-066:21 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
13,038
$1.63
6,372,438(Indirect)
View


2016-07-01Option Award
2016-07-066:21 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
13,038
$1.63
6,372,438(Indirect)
View


2016-07-01Option Award
2016-07-066:21 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
13,038
$1.63
6,372,438(Indirect)
View


2016-06-30Option Award
2016-07-055:13 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
237
$79.98
19,757,784(Indirect)
View


2016-06-30Option Award
2016-07-055:13 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
237
$79.98
19,757,784(Indirect)
View


2016-06-30Option Award
2016-07-055:13 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
237
$79.98
19,757,784(Indirect)
View


2016-06-13Option Award
2016-06-155:09 pm
N/A2026-06-13
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Baker Bros. Advisors (gp) LLCDirector
70,000
$1.44
70,000(Indirect)
View


2016-06-10Option Award
2016-06-134:46 pm
N/A2026-06-09
Acadia Pharmaceuticals Inc
ACAD
Baker BROS. Advisors LpBaker Brothers Life Sciences LpBaker Bros. Advisors (gp) LLCBaker FelixBaker Julian667 L.P.14159 L.P.Director10% Owner
26,500
$39.6
26,500(Indirect)
View


2016-06-10Option Award
2016-06-134:44 pm
2017-06-102026-06-10
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
20,000
$26.18
20,000(Indirect)
View


2016-05-27Option Award
2016-05-315:53 pm
2017-05-272026-05-26
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
15,000
$84.53
15,000(Indirect)
View


2016-05-17Exercise
2016-05-196:23 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
8,250
$10.73
11,258,316(Indirect)
View


2016-05-17Exercise
2016-05-196:23 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
8,250
$10.73
11,258,316(Indirect)
View


2016-05-17Exercise
2016-05-196:23 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
8,250
$10.73
11,258,316(Indirect)
View


2016-05-17Exercise
2016-05-196:23 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
8,250
$10.73
11,258,316(Indirect)
View


2016-05-17Exercise
2016-05-196:23 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
8,250
$10.73
11,258,316(Indirect)
View


2016-05-17Exercise
2016-05-196:23 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
8,250
$10.73
11,258,316(Indirect)
View


2016-05-17Exercise
2016-05-196:23 pm
2007-05-232016-05-24
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
8,250
$10.73
11,258,316(Indirect)
View


2016-05-17Exercise
2016-05-196:23 pm
2007-05-232016-05-24
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
8,250
$10.73
11,258,316(Indirect)
View


2016-05-17Exercise
2016-05-196:23 pm
2007-05-232016-05-24
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
8,250
$10.73
11,258,316(Indirect)
View


2016-05-17Exercise
2016-05-196:23 pm
2007-05-232016-05-24
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
8,250
$10.73
11,258,316(Indirect)
View


2016-05-17Exercise
2016-05-196:23 pm
2007-05-232016-05-24
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
8,250
$10.73
11,258,316(Indirect)
View


2016-05-17Exercise
2016-05-196:23 pm
2007-05-232016-05-24
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
8,250
$10.73
11,258,316(Indirect)
View


2016-04-01Option Award
2016-04-056:00 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
10,788
$1.97
6,359,400(Indirect)
View


2016-04-01Option Award
2016-04-056:00 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
10,788
$1.97
6,359,400(Indirect)
View


2016-04-01Option Award
2016-04-056:00 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker Bros. Advisors (gp) LLCBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Director
10,788
$1.97
6,359,400(Indirect)
View


2016-04-01Option Award
2016-04-055:58 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
784
$25.48
11,250,066(Indirect)
View


2016-04-01Option Award
2016-04-055:58 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
784
$25.48
11,250,066(Indirect)
View


2016-04-01Option Award
2016-04-055:58 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
784
$25.48
11,250,066(Indirect)
View


2016-04-01Option Award
2016-04-055:58 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
784
$25.48
11,250,066(Indirect)
View


2016-04-01Option Award
2016-04-055:58 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
784
$25.48
11,250,066(Indirect)
View


2016-04-01Option Award
2016-04-055:58 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
784
$25.48
11,250,066(Indirect)
View


2016-03-31Option Award
2016-04-046:32 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
262
$72.47
19,757,548(Indirect)
View


2016-03-31Option Award
2016-04-046:32 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
262
$72.47
19,757,548(Indirect)
View


2016-03-31Option Award
2016-04-046:32 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
262
$72.47
19,757,548(Indirect)
View


2016-03-15Exercise
2016-03-177:14 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
20,000
$3.86
19,757,284(Indirect)
View


2016-03-15Exercise
2016-03-177:14 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
20,000
$3.86
19,757,284(Indirect)
View


2016-03-15Exercise
2016-03-177:14 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
20,000
$3.86
19,757,284(Indirect)
View


2016-03-15Exercise
2016-03-177:14 pm
2007-05-232016-05-22
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
20,000
$3.86
19,757,284(Indirect)
View


2016-03-15Exercise
2016-03-177:14 pm
2007-05-232016-05-22
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
20,000
$3.86
19,757,284(Indirect)
View


2016-03-15Exercise
2016-03-177:14 pm
2007-05-232016-05-22
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
20,000
$3.86
19,757,284(Indirect)
View


2016-02-08Conversion
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
4,382,118
$0
73,162,024(Indirect)
View


2016-02-08Conversion
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
44,572,172
$0
73,162,024(Indirect)
View


2016-02-08Conversion
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
582,747
$0
73,162,024(Indirect)
View


2016-02-08Conversion
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
1,912,167
$0
73,162,024(Indirect)
View


2016-02-08Conversion
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
26,292,960
$0
73,162,024(Indirect)
View


2016-02-08Exercise
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
238,850
$0.675
73,162,024(Indirect)
View


2016-02-08Exercise
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
2,296,890
$0.675
73,162,024(Indirect)
View


2016-02-08Exercise
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
56,853
$0.675
73,162,024(Indirect)
View


2016-02-08Conversion
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
4,382,118
$0
73,162,024(Indirect)
View


2016-02-08Conversion
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
44,572,172
$0
73,162,024(Indirect)
View


2016-02-08Conversion
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
582,747
$0
73,162,024(Indirect)
View


2016-02-08Conversion
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
1,912,167
$0
73,162,024(Indirect)
View


2016-02-08Conversion
2016-02-095:38 pm
N/AN/A
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
26,292,960
$0
73,162,024(Indirect)
View


2016-02-08Exercise
2016-02-095:38 pm
2014-08-122019-08-12
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
238,850
$0.675
73,162,024(Indirect)
View


2016-02-08Exercise
2016-02-095:38 pm
2014-08-122019-08-12
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
2,296,890
$0.675
73,162,024(Indirect)
View


2016-02-08Exercise
2016-02-095:38 pm
2014-08-122019-08-12
Beigene Ltd.
BGNE
Baker BROS. Advisors LpBaker Bros. Advisors (gp) LLCBaker JulianBaker Felix667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
56,853
$0.675
73,162,024(Indirect)
View


2016-01-04Option Award
2016-01-066:02 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Baker Bros. Advisors (gp) LLCDirector
7,082
$3
6,348,612(Indirect)
View


2016-01-04Option Award
2016-01-066:02 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Baker Bros. Advisors (gp) LLCDirector
7,082
$3
6,348,612(Indirect)
View


2016-01-04Option Award
2016-01-066:02 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Baker Bros. Advisors (gp) LLCDirector
7,082
$3
6,348,612(Indirect)
View


2016-01-01Option Award
2016-01-056:47 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
568
$35.2
11,249,282(Indirect)
View


2016-01-01Option Award
2016-01-056:47 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
568
$35.2
11,249,282(Indirect)
View


2016-01-01Option Award
2016-01-056:47 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
568
$35.2
11,249,282(Indirect)
View


2016-01-01Option Award
2016-01-056:47 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
568
$35.2
11,249,282(Indirect)
View


2016-01-01Option Award
2016-01-056:47 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
568
$35.2
11,249,282(Indirect)
View


2016-01-01Option Award
2016-01-056:47 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
568
$35.2
11,249,282(Indirect)
View


2015-12-31Option Award
2016-01-056:22 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
175
$108.4
16,129,274(Indirect)
View


2015-12-31Option Award
2016-01-056:22 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
175
$108.4
16,129,274(Indirect)
View


2015-12-31Option Award
2016-01-056:22 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
175
$108.4
16,129,274(Indirect)
View


2015-12-11Option Award
2015-12-155:47 pm
N/A2025-12-10
Acadia Pharmaceuticals Inc
ACAD
Baker BROS. Advisors LpBaker FelixBaker Julian667 L.P.14159 L.P.Baker Brothers Life Sciences LpBaker Bros. Advisors (gp) LLCDirector10% Owner
15,000
$32.5
15,000(Indirect)
View


2015-10-01Option Award
2015-10-057:17 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
936
$21.34
11,248,714(Indirect)
View


2015-10-01Option Award
2015-10-057:17 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
936
$21.34
11,248,714(Indirect)
View


2015-10-01Option Award
2015-10-057:17 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
936
$21.34
11,248,714(Indirect)
View


2015-10-01Option Award
2015-10-057:17 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
936
$21.34
11,248,714(Indirect)
View


2015-10-01Option Award
2015-10-057:17 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
936
$21.34
11,248,714(Indirect)
View


2015-10-01Option Award
2015-10-057:17 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Director10% Owner
936
$21.34
11,248,714(Indirect)
View


2015-10-01Option Award
2015-10-057:04 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
172
$110.3
16,129,099(Indirect)
View


2015-10-01Option Award
2015-10-057:04 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
172
$110.3
16,129,099(Indirect)
View


2015-10-01Option Award
2015-10-057:04 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
172
$110.3
16,129,099(Indirect)
View


2015-10-01Option Award
2015-10-056:59 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Baker Bros. Advisors (gp) LLCDirector
6,945
$3.06
6,341,530(Indirect)
View


2015-10-01Option Award
2015-10-056:59 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Baker Bros. Advisors (gp) LLCDirector
6,945
$3.06
6,341,530(Indirect)
View


2015-10-01Option Award
2015-10-056:59 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Baker Bros. Advisors (gp) LLCDirector
6,945
$3.06
6,341,530(Indirect)
View


2015-09-16Exercise
2015-09-186:33 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
7,292
$0
16,128,927(Direct)
View


2015-09-16Exercise
2015-09-186:33 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
7,406
$0
16,128,927(Direct)
View


2015-09-16Exercise
2015-09-186:33 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
864,614
$0
16,128,927(Indirect)
View


2015-09-16Exercise
2015-09-186:33 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
3,642,962
$0
16,128,927(Indirect)
View


2015-09-16Exercise
2015-09-186:33 pm
N/AN/A
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
101,652
$0
16,128,927(Indirect)
View


2015-09-16Exercise
2015-09-186:33 pm
2009-09-242015-10-01
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
64,000
$8.775
16,128,927(Direct)
View


2015-09-16Exercise
2015-09-186:33 pm
2009-09-242015-10-01
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
65,000
$8.775
16,128,927(Direct)
View


2015-09-16Exercise
2015-09-186:33 pm
2009-09-242015-10-01
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
7,587,000
$8.775
16,128,927(Indirect)
View


2015-09-16Exercise
2015-09-186:33 pm
2009-09-242015-10-01
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
31,967,000
$8.775
16,128,927(Indirect)
View


2015-09-16Exercise
2015-09-186:33 pm
2009-09-242015-10-01
Incyte Corp
INCY
Baker JulianBaker FelixBaker BROS. Advisors Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker Bros. Advisors (gp) LLCDirector10% Owner
892,000
$8.775
16,128,927(Indirect)
View


2015-07-01Option Award
2015-07-066:25 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Baker Bros. Advisors (gp) LLCDirector
5,260
$3.66
6,334,585(Indirect)
View


2015-07-01Option Award
2015-07-066:25 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Baker Bros. Advisors (gp) LLCDirector
5,260
$3.66
6,334,585(Indirect)
View


2015-07-01Option Award
2015-07-066:25 pm
N/AN/A
Idera Pharmaceuticals Inc
IDRA
Baker JulianBaker BROS. Advisors LpBaker Brothers Life Sciences Lp14159 L.P.Baker Felix667 L.P.Baker Bros. Advisors (gp) LLCDirector
5,260
$3.66
6,334,585(Indirect)
View


2015-07-01Option Award
2015-07-065:42 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCDirector10% Owner
730
$27.34
11,247,778(Indirect)
View


2015-07-01Option Award
2015-07-065:42 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCDirector10% Owner
730
$27.34
11,247,778(Indirect)
View


2015-07-01Option Award
2015-07-065:42 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCDirector10% Owner
730
$27.34
11,247,778(Indirect)
View


2015-07-01Option Award
2015-07-065:42 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCDirector10% Owner
730
$27.34
11,247,778(Indirect)
View


2015-07-01Option Award
2015-07-065:42 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCDirector10% Owner
730
$27.34
11,247,778(Indirect)
View


2015-07-01Option Award
2015-07-065:42 pm
N/AN/A
Genomic Health Inc
GHDX
Baker FelixBaker Bros. Investments L.P.Baker Bros. Investments II L.P.Baker/tisch Investments Lp667 L.P.Baker Brothers Life Sciences Lp14159 L.P.Baker BROS. Advisors LpBaker JulianBaker Bros. Advisors (gp) LLCDirector10% Owner
730
$27.34
11,247,778(Indirect)
View





Goto page 0,
1,
Next





    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Tue, 25 Jul 2017 04:09:18 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  











14159, L.P. Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      14159, L.P.
                    

•   NEW YORK, NY
                      
How do I update this listing?




                                             14159 is based out of New York.    WhaleWisdom has at least 1 insider transactions (Form 3,4,5) in our database for 14159. 
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from 14159, L.P., enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




14159, l.p.


667 MADISON AVE.

NEW YORK
NY
                                                        
                                                    10065


                                                      Business Phone:
                                                      212-339-5600
SEC SIC CODE:2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)







Recent SEC Filings




4 filed on 07/06/2017
4 filed on 07/05/2017
4 filed on 06/20/2017
4 filed on 06/14/2017
4/A filed on 06/09/2017
4 filed on 06/08/2017
4 filed on 06/01/2017
4 filed on 05/31/2017
4 filed on 04/28/2017
4 filed on 04/21/2017
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free



















Form  4          14159, L.P.               For: Oct 01  Filed by: Baker/Tisch Investments, LP

















































Close (X)
	Set up related e-mail alerts – FREE!






Categories
Entities
Stocks
Sign up!



SEC Filings







GHDX





E-mail Address




















 













Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio



Upgrade to StreetInsider Premium! - Free Trial








 




Home


Menu

JOIN
SI Premium
Ratings
M&A Insider
EPS Insider
Dividends
IPO Insider
Hedge Funds
Premium Letters
Submit Release


JOIN

SI Premium

Full Feed View
Headline View
SI Premium Squawk Box
Alerts
Custom Headlines 
UPGRADE TO SI PREMIUM
License



Calendars

Dividend Calendar
Earnings Calendar
Event Driven
FDA Calendar
Investor Conferences
IPO Calendar
Merger Arb
Ratings Calendar
Stock Split Calendar 



Ratings

Analyst Comments
Hot Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades
New Coverage News
Hot New Coverage
Upgrade News
Hot Upgrades
More...



M&A Insider

Merger News
Hot M&A News
Private Equity
Rumors
Spinoffs
Merger Arbitrage
Event Driven
2017 Top M&A Deals
Top 50 Takeover Targets
More...



EPS Insider

Earnings Calendar
Earnings News
Hot Earnings
Guidance
Hot Guidance
Conference Calls
Earnings History Search
More...



Dividends

Dividend Calendar
Dividend News
Hot Dividends
Dividend Hike
Special Dividends
Stock Buybacks
Hot Stock Buybacks
Stock Splits
More...



IPO Insider

IPO News
Hot IPOs
Equity Offerings
Recent IPOs
Upcoming IPOs
2017 Top IPOs
More...



Hedge Funds

13D
13F
13G
Hedge Funds News
Hot Insider Trades
Insider Trades
More...



Premium Letters

NEW *** Dividend Insider Elite
Pulse Picks
Ratings Insider Elite
Stealth Growth Insider


Submit Release





QUICK LINKS :
Goldman Sachs Conviction Buy List
Carl Icahn News
Warren Buffett News
Ackman News

Follow @Street_Insider









SEC Filings







Form  4          14159, L.P.               For: Oct 01  Filed by: Baker/Tisch Investments, LP

Article
Stock Quotes (1)
Comments (0)


October 5, 2015 7:17 PM EDT

 Tweet
 Share
 E-mail
0 shares










Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.



FORM
				4

UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities
					Exchange Act of 1934or Section 30(h) of the Investment Company Act of
					1940


OMB APPROVAL


OMB Number:
3235-0287


Expires:
December 31, 2014

Estimated average burden

hours per response:
0.5





  

				Check this box if no longer subject to Section 16. Form 4 or Form 5
				obligations may continue.
				See

				Instruction 1(b).
			






                    1. Name and Address of Reporting Person
                    *BAKER FELIX


(Last)
(First)
(Middle)


667 MADISON AVENUE, 21ST FLOOR



(Street)
NEW YORK
NY
US 10065



(City)
(State)
(Zip)




                    2. Issuer Name
                    and
                    Ticker or Trading Symbol
                GENOMIC HEALTH INC
                    [
                    GHDX
                    ]
            

5. Relationship of Reporting Person(s) to Issuer
                (Check all applicable)

X
Director
X
10% Owner



Officer (give title below)

Other (specify below)






3. Date of Earliest Transaction
                    (Month/Day/Year)10/01/2015



4. If Amendment, Date of Original Filed
                    (Month/Day/Year)


6. Individual or Joint/Group Filing (Check
                    Applicable Line)
                


Form filed by One Reporting Person


X
Form filed by More than One Reporting
                            Person







Table I - Non-Derivative Securities Acquired, Disposed of, or
						Beneficially Owned

1.
					Title of Security (Instr.
					3)
				
2.
					Transaction Date
					(Month/Day/Year)
2A.
					Deemed Execution Date, if any
					(Month/Day/Year)
3.
					Transaction Code (Instr.
					8)
				
4.
					Securities Acquired (A) or Disposed Of (D) (Instr.
					3, 4 and 5)
				
5.
					Amount of Securities Beneficially Owned Following Reported
					Transaction(s) (Instr.
					3 and 4)
				
6.
					Ownership Form: Direct (D) or Indirect (I) (Instr.
					4)
				
7.
					Nature of Indirect Beneficial Ownership (Instr.
					4)
				


Code
V
Amount
(A) or (D)
Price





                Common Stock
            

							 
						

							 
						

							 
						

							 
						

							 
						

							 
						

						 
					

                    173,897
                

                    I
                

                    See footnote
                    
		  (1)
		




                Common Stock
            
10/01/2015

							 
						
A

							 
						

                    936
                

                    A
                

$
                    21.34
                


                    202,590
                

                    I
                

                    See footnote
                    
		  (2)
		

		  (3)
		

		  (9)
		

		  (10)
		




                Common Stock
            
10/01/2015

							 
						
A

							 
						

                    936
                

                    A
                

$
                    21.34
                


                    182,326
                

                    I
                

                    See footnote
                    
		  (2)
		

		  (4)
		

		  (9)
		

		  (10)
		




                Common Stock
            
10/01/2015

							 
						
A

							 
						

                    936
                

                    A
                

$
                    21.34
                


                    21,667
                

                    I
                

                    See footnote
                    
		  (2)
		

		  (5)
		

		  (9)
		

		  (10)
		




                Common Stock
            
10/01/2015

							 
						
A

							 
						

                    936
                

                    A
                

$
                    21.34
                


                    1,737,837
                

                    I
                

                    See footnote
                    
		  (2)
		

		  (6)
		

		  (9)
		

		  (10)
		




                Common Stock
            
10/01/2015

							 
						
A

							 
						

                    936
                

                    A
                

$
                    21.34
                


                    11,248,714
                

                    I
                

                    See footnote
                    
		  (2)
		

		  (7)
		

		  (9)
		

		  (10)
		




                Common Stock
            
10/01/2015

							 
						
A

							 
						

                    936
                

                    A
                

$
                    21.34
                


                    308,275
                

                    I
                

                    See footnote
                    
		  (2)
		

		  (8)
		

		  (9)
		

		  (10)
		







Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities)


1. Title of Derivative Security (Instr. 
      3)
   
2. Conversion or Exercise Price of Derivative Security
   
3. Transaction Date
      (Month/Day/Year)
3A. Deemed Execution Date, if any
      (Month/Day/Year)
4. Transaction Code (Instr. 
      8)
   
5. 
      Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 
      3, 4 and 5)
   
6. Date Exercisable and Expiration Date 
      (Month/Day/Year)
7. Title and Amount of Securities Underlying Derivative Security (Instr. 
      3 and 4)
   
8. Price of Derivative Security (Instr. 
      5)
   
9. 
      Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 
      4)
   
10. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      4)
   
11. Nature of Indirect Beneficial Ownership (Instr. 
      4)
   


Code
V
(A)
(D)
Date Exercisable
Expiration Date
Title
Amount or Number of Shares





Explanation of Responses:

1. Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest in 173,897 shares of Common Stock of Genomic Health, Inc. (the "Issuer") directly held by FBB Associates. Julian C. Baker and Felix J. Baker are the sole partners of FBB Associates. Julian C. Baker and Felix J. Baker disclaim beneficial ownership of the securities held directly by FBB Associates except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that either Julian C. Baker or Felix J. Baker is a beneficial owner of such securities for purposes of Section 16 or any other purpose.

2. 468 shares of restricted stock (the "Restricted Stock") issued to Felix J. Baker and 468 shares of Restricted Stock issued to Julian C. Baker pursuant to the Issuer's 2005 Stock Incentive Plan (the "Stock Incentive Plan") in lieu of director retainer fees of $10,000, respectively. The shares of Restricted Stock are fully vested. Felix J. Baker and Julian C. Baker serve on the Issuer's Board of Directors as representatives of the Funds (as defined below). Pursuant to the policies of the Adviser (as defined below), Felix J. Baker and Julian C. Baker do not have any right to the pecuniary interest in the Issuer's securities issued in lieu of director retainer fees and the Funds (as defined below)are entitled to an indirect proportionate pecuniary interest in the securities issued in lieu of director fees. Baker/Tisch Investments, L.P. ("Baker Tisch"), Baker Bros. Investments, L.P. ("Baker Bros. Investments"), Baker Bros. Investments II, L.P. ("Baker Bros. Investments II"), 667, L.P. ("667"), Baker Brothers Life Sciences, L.P. ("Life Sciences") and 14159, L.P. ("14159", and together with Baker Tisch, Baker Bros. Investments, Baker Bros. Investments II, 667, and Life Sciences, the "Funds") each owns an indirect  proportionate pecuniary interest in the shares of Restricted Stock. Solely as a result of their ownership interest in the general partners of the general partners of the Funds, Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest in the shares of Restricted Stock issued in lieu of director retainer fees (ie. no direct pecuniary interest).

3. As a result of Felix J. Baker's and Julian C. Baker's ownership interest in Baker/Tisch Capital (GP), LLC, Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest in 202,590 shares of Common Stock of the Issuer beneficially owned by Baker Tisch, a limited partnership of which the sole general partner is Baker/Tisch Capital, L.P., a limited partnership of which the sole general partner is Baker/Tisch Capital (GP), LLC, due to Baker/Tisch Capital, L.P.'s right to receive an allocation of a portion of the profits from Baker Tisch. Includes beneficial ownership of 8,429 shares issued pursuant to the Stock Incentive Plan in lieu of director retainer fees, of which the fund may be deemed to own a portion.

4. As a result of Felix J. Baker's and Julian C. Baker's ownership interest in Baker Bros. Capital (GP), LLC, Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest in 182,326 shares of Common Stock of the Issuer beneficially owned by Baker Bros. Investments, a limited partnership of which the sole general partner is Baker Bros. Capital, L.P., a limited partnership of which the sole general partner is Baker Bros. Capital (GP), LLC, due to Baker Bros. Capital, L.P.'s right to receive an allocation of a portion of the profits from Baker Bros. Investments. Includes beneficial ownership of 8,429 shares issued pursuant to the Stock Incentive Plan in lieu of director retainer fees, of which the fund may be deemed to own a portion.

5. As a result of Felix J. Baker's and Julian C. Baker's ownership interest in Baker Bros. Capital (GP), LLC, Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest in 21,667 shares of Common Stock of the Issuer beneficially owned by Baker Bros. Investments II, a limited partnership of which the sole general partner is Baker Bros. Capital, L.P., a limited partnership of which the sole general partner is Baker Bros. Capital (GP), LLC, due to Baker Bros. Capital, L.P.'s right to receive an allocation of a portion of the profits from Baker Bros. Investments II. Includes beneficial ownership of 8,429 shares issued pursuant to the Stock Incentive Plan in lieu of director retainer fees, of which the fund may be deemed to own a portion.

6. As a result of Felix J. Baker's and Julian C. Baker's ownership interest in Baker Biotech Capital (GP), LLC, Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest in 1,737,837 shares of Common Stock of the Issuer beneficially owned by 667, a limited partnership of which the sole general partner is Baker Biotech Capital, L.P., a limited partnership of which the sole general partner is Baker Biotech Capital (GP), LLC, due to Baker Biotech Capital, L.P.'s right to receive an allocation of a portion of the profits from 667. Includes beneficial ownership of 8,429 shares issued pursuant to the Stock Incentive Plan in lieu of director retainer fees, of which the fund may be deemed to own a portion.

7. As a result of Felix J. Baker's and Julian C. Baker's ownership interest in Baker Brothers Life Sciences Capital (GP), LLC, Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest 11,248,714 shares of Common Stock of the Issuer beneficially owned by Life Sciences, a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital, L.P., a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital (GP), LLC, due to Baker Brothers Life Sciences Capital, L.P.'s right to receive an allocation of a portion of the profits from Life Sciences. Includes beneficial ownership of 8,429 shares issued pursuant to the Stock Incentive Plan in lieu of director retainer fees, of which the fund may be deemed to own a portion.

8. As a result of Felix J. Baker's and Julian C. Baker's ownership interest in 14159 Capital (GP), LLC, Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest in 308,275 shares of Common Stock of the Issuer beneficially owned by 14159, a limited partnership of which the sole general partner is 14159 Capital, L.P., a limited partnership of which the sole general partner is 14159 Capital (GP), LLC, due to 14159 Capital, L.P.'s right to receive an allocation of a portion of the profits from 14159. Includes beneficial ownership of 8,429 shares issued pursuant to the Stock Incentive Plan in lieu of director retainer fees, of which the fund may be deemed to own a portion.

9. Baker Bros. Advisors LP (the "Adviser") serves as the Investment Adviser to the Funds. In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held by the Funds. Baker Bros. Advisors (GP) LLC (the "Adviser GP") is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are principals of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held by the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held by the Funds. Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose.

10. The disclosure of the grant of Restricted Stock reported on this form is the sum of two grants totaling 936 shares. The 936 shares are reported for each limited partnership as each has an indirect pecuniary interest.
Remarks:
Felix J. Baker and Julian C. Baker are directors of Genomic Health Inc. (the "Issuer"). By virtue of their representation on the Board of Directors of the Issuer, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the reporting persons are deemed directors by deputization of the Issuer.




/s/ Felix J. Baker
10/05/2015



** Signature of Reporting Person
Date



Name: Scott L. Lessing Title: President /s/ Scott L. Lessing
10/05/2015



** Signature of Reporting Person
Date



/s/ Julian C. Baker
10/05/2015



** Signature of Reporting Person
Date



Name: Scott L. Lessing Title: President /s/ Scott L. Lessing
10/05/2015



** Signature of Reporting Person
Date



Baker Bros. Advisors LP, Mgmt. Co. and Inv. Adviser to Baker Bros. Investments, L.P., pursuant to authority granted by Baker Bros. Capital, L.P., GP to Baker Bros. Investments, L.P Name: Scott L. Lessing, Title: President /s/ Scott L. Lessing
10/05/2015



** Signature of Reporting Person
Date



Baker Bros. Advisors LP, Mgmt. Co. and Inv. Adviser to Baker Bros. Investments II, L.P., pursuant to authority granted by Baker Bros. Capital, L.P., GP to Baker Bros. Investments II, L.P Name: Scott L. Lessing, Title: President /s/ Scott L. Lessing
10/05/2015



** Signature of Reporting Person
Date



Baker Bros. Advisors LP, Mgmt. Co. and Inv. Adviser to BAKER/TISCH INVESTMENTS, L.P., pursuant to authority granted by Baker/Tisch Capital, L.P., GP to Baker/Tisch Investment, L.P Name: Scott L. Lessing, Title: President /s/ Scott L. Lessing
10/05/2015



** Signature of Reporting Person
Date



Baker Bros. Advisors LP, Mgmt. Co. and Inv. Adviser to 667, L.P., pursuant to authority granted by Baker Biotech Capital, L.P., GP to 667, L.P Name: Scott L. Lessing, Title: President /s/ Scott L. Lessing
10/05/2015



** Signature of Reporting Person
Date



Baker Bros. Advisors LP, Mgmt. Co. and Inv. Adviser to BAKER BROTHERS LIFE SCIENCES, L.P., pursuant to authority granted by Baker Brothers Life Sciences Capital, L.P., GP to Baker Brothers Life Sciences, L.P Name:Scott L. Lessing, Title: President /s/
10/05/2015



** Signature of Reporting Person
Date



Baker Bros. Advisors LP, Mgmt. Co. and Inv. Adviser to 14159, L.P., pursuant to authority granted by 14159 Capital, L.P., GP to 14159, L.P Name:Scott L. Lessing, Title: President /s/ Scott L. Lessing
10/05/2015



** Signature of Reporting Person
Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, 
                  see

                  Instruction 
                  4

                  (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations 
                  See

                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, 
                  see

                  Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.














FREE Breaking News Alerts from StreetInsider.com!


E-mail Address








StreetInsider.com Top Tickers, 7/25/2017

1. GOOGL
2. APRN
3. AMZN
4. GOOG
5. AAPL


6. HIBB
7. WBMD
8. HAL
9. TWTR
10. HAS













Top News
Most Read
Special Reports



Alphabet (GOOG) Tops Q2 EPS by 52c, Revs Beat
Nasdaq, tech shine as earnings pick up; Dow, S&P lag
Novavax (NVAX) Reports Topline Data from Phase 2 Older Adult Trial for RSV F Vaccine Programs; Offers Update on Path Forward
Blue Apron (APRN) Gains as Wall Street Issues a Collective 'Buy' on Beaten-Down IPO
After-Hours Movers 7/24: (RMBS) (SWFT) (HDP) Higher; (NVAX) (SANM) (GOOGL) Lower (more...)




Tupperware Brands (TUP) Winds-Down Beauticontrol Unit After Unsuccessful Sale
UBS Downgrades Goldman Sachs (GS) to Neutral
Novavax (NVAX) Reports Topline Data from Phase 2 Older Adult Trial for RSV F Vaccine Programs; Offers Update on Path Forward
Cytori Therapeutics (CYTX) STAR Trial of Habeo Cell Therapy in Patients with Scleroderma Doesn't Met Primary Endpoint
AMD (AMD) Short Sellers Raise Bets Into Results




After-Hours Movers 7/24: (RMBS) (SWFT) (HDP) Higher; (NVAX) (SANM) (GOOGL) Lower (more...)
Pre-Open Movers 07/24: (WBMD) (NDRM) (APRN) Higher; (HIBB) (BGFV) (DKS) Lower (more...)
Pre-Open Movers 07/21: (PLUG) (AEZS) (ATHN) Higher; (MANH) (SMCI) (NCR) Lower (more...)
After-Hours Stock Movers 07/20: (AEZS) (ATHN) (MSFT) Higher; (MANH) (NCR) (MXIM) Lower (more...)
Pre-Open Movers 07/20: (HPJ) (SHLD) (SRPT) Higher; (PTC) (CHRW) (FMSA) Lower (more...)











Serious News for Serious Traders!  Try StreetInsider.com Premium Free!

You May Also Be Interested In

Genomic Health to Announce Second Quarter 2017 Financial Results and Host Conference Call on Tuesday, August 1, 2017
Blue Pearl Software Streamlines RTL Verification for Xilinx All Programmable FPGAs and SoCs
The Digital Awards Submission Deadline is Extended through Friday, July 28; Digital Firms and Communicators Should Enter Their Top Campaigns for Recognition in November 2


























Create E-mail Alert
	Related Categories
	
SEC Filings 




Login with Facebook


Add Your Comment

Name


Subject

Body


Share on Facebook



Verification

can't see the text? click here to refresh the image.
what's this?




Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!









 























 Free News FeedGet our RSS Feed!


© Copyright 2017 StreetInsider.com



Home
Member's Home
Premium Content


Links
Entities
About StreetInsider
Get Our Content


Advertise with Us
Contact Us
Disclaimer
Privacy Policy



















Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version























14159, L.P. Insider Insider Trades - NASDAQ.com





















































Hot Topics:
ETFs |
Smart Portfolio |
Currencies |
Online Broker Center















Search






















Home > 
    Quotes > 
    Ownership & Insider Trades > 
    Individual Insiders






Insider Trades of 14159, L.P.





Click on the column header to resort ascending (▲) or descending (▼).



Individual Insider Trades



Company


Relation


Last Date ▼


Type


Tran


OwnerType


Shares Traded


Last Price


Shares Held



ACADIA PHARMACEUTICALS INC
Director
01/07/2016
Form 4
Buy
indirect
2,586,206
29
23,067,648















Highest Rated Articles of Last Week



Yatra Attains Leadership Position in Corporate Travel With the...
Merck and Pfizer Collaborate with Corning to Modernize ...
PetIQ, Inc. (Nasdaq: PETQ) to Ring The Nasdaq Stock Market Opening...
South Alabama Property Receives CSX Select Site Designation
GameStop and ThinkGeek Bring Comic-Con to You





View All Highest Rated































Most Rated Stocks of Last Week
Rated stocks for NASDAQ, NYSE and AMEX

Symbol  /  Ratings Consensus

AAPL

86% bullish
                    of
                    2909
                    ratings
Rate It


GOOG

91% bullish
                    of
                    128
                    ratings
Rate It


JPM

69% bullish
                    of
                    88
                    ratings
Rate It


FB

76% bullish
                    of
                    1325
                    ratings
Rate It


NFLX

68% bullish
                    of
                    323
                    ratings
Rate It


NVDA

83% bullish
                    of
                    129
                    ratings
Rate It


MSFT

84% bullish
                    of
                    648
                    ratings
Rate It


BAC

75% bullish
                    of
                    474
                    ratings
Rate It


TWTR

67% bullish
                    of
                    207
                    ratings
Rate It


AMD

85% bullish
                    of
                    179
                    ratings
Rate It


More Most Rated Stocks



























CLOSEX

Edit Favorites

Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.






Update

Clear List







CLOSEX
Customize your NASDAQ.com experience
Background Color Selector

Select the background color of your choice:





 Black
							





 Slate Gray
							






 Light Gray
							





 Gray Blue
							






Quote Search

Select a default target page for your quote search:



						 Real-Time

						 After Hours

						 Pre-Market
 News
					


						 Flash Quote

						 Summary Quote

						 Interactive Charts

						 Default Setting




					Please note that once you make your selection, it will apply to all future visits to NASDAQ.com.
					If, at any time, you are interested in reverting to our default settings, please select Default Setting above.
					
					If you have any questions or encounter any issues in changing your default settings, please email isfeedback@nasdaq.com.
				





CLOSEX
Please confirm your selection:

					You have selected to change your default setting for the Quote Search. This will now be your default target page;
					unless you change your configuration again, or you delete your
					cookies. Are you sure you want to change your settings?


YES
NO













CLOSEX


Please disable your ad blocker (or update your settings to ensure that javascript and cookies are enabled), so that we can continue to provide you with the first-rate market news and data you've come to expect from us.





CLOSEX












































 SECGems: 14159, L.P. 







































  







			Data feeds now available
			Excel / CSV / Java / Python /etc 
Database
Learn more









  




  


  






























 14159, L.P. 
		     










 Info




 Ownership




 Filings














←


 1 


 2 


 3 


 4 


 5 


→



 Ownership filings:    (1 of 20 - Total: 146)








Filing date
2017-07-06
Submission
 0001638599-17-000689.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 IDERA PHARMACEUTICALS, INC.  IDRA

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-07-034A : Grant / awardFalse117871.75A1038224ISee footnotes
Non-Derriv. transCommon Stock2017-07-034A : Grant / awardFalse117871.75A9343776ISee footnotes
Non-Derriv. transCommon Stock2017-07-034A : Grant / awardFalse117871.75A145453ISee footnotes












Filing date
2017-07-05
Submission
 0001638599-17-000684.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 GENOMIC HEALTH INC  GHDX

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Investments II, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Investments, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker/Tisch Investments, LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-07-014A : Grant / awardFalse61432.55A223806ISee footnotes
Non-Derriv. transCommon Stock2017-07-014A : Grant / awardFalse61432.55A203542ISee footnotes
Non-Derriv. transCommon Stock2017-07-014A : Grant / awardFalse61432.55A42883ISee footnotes
Non-Derriv. transCommon Stock2017-07-014A : Grant / awardFalse61432.55A1769157ISee footnotes
Non-Derriv. transCommon Stock2017-07-014A : Grant / awardFalse61432.55A11359826ISee footnotes
Non-Derriv. transCommon Stock2017-07-014A : Grant / awardFalse61432.55A329491ISee footnotes
Non-Derriv. holdingCommon Stock173897ISee footnotes












Filing date
2017-07-05
Submission
 0001638599-17-000677.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 INCYTE CORP  INCY

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-06-304A : Grant / awardFalse150125.91A4374249ISee Footnotes
Non-Derriv. transCommon Stock2017-06-304A : Grant / awardFalse150125.91A29161945ISee Footnotes
Non-Derriv. transCommon Stock2017-06-304A : Grant / awardFalse150125.91A787387ISee Footnotes
Non-Derriv. holdingCommon Stock58632D
Non-Derriv. holdingCommon Stock61049D
Non-Derriv. holdingCommon Stock33410ISee Footnotes












Filing date
2017-06-20
Submission
 0001638599-17-000643.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 GENOMIC HEALTH INC  GHDX

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Investments II, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Investments, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker/Tisch Investments, LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Derriv. transNon-Qualified Stock Options (right to buy)31.532017-06-164A : Grant / awardFalse200000A2018-06-162027-06-1620000Common Stock20000ISee Footnotes












Filing date
2017-06-14
Submission
 0001638599-17-000592.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 ACADIA PHARMACEUTICALS INC  ACAD

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Derriv. transNon-Qualified Stock Option (right to buy)27.252017-06-134A : Grant / awardFalse300000A2027-06-1230000Common Stock30000ISee Footnotes












Filing date
2017-06-09
Submission
 0001638599-17-000566.nc

Form
4/A  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 IDERA PHARMACEUTICALS, INC.  IDRA

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Derriv. transNon-Qualified Stock Option (right to buy)1.632017-06-074A : Grant / awardFalse1000000A2027-06-07100000Common Stock100000ISee Footnotes












Filing date
2017-06-08
Submission
 0001638599-17-000565.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 IDERA PHARMACEUTICALS, INC.  IDRA

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Derriv. transNon-Qualified Stock Option (right to buy)1.632017-06-074A : Grant / awardFalse1000000A2027-06-07100000Common Stock100000ISee Footnotes












Filing date
2017-06-01
Submission
 0001638599-17-000515.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 GENOMIC HEALTH INC  GHDX

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Investments II, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Investments, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker/Tisch Investments, LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-05-314M : Exer. or conv. of deriv. security exemptedFalse825018.13A223192ISee footnotes
Non-Derriv. transCommon Stock2017-05-314M : Exer. or conv. of deriv. security exemptedFalse825018.13A202928ISee footnotes
Non-Derriv. transCommon Stock2017-05-314M : Exer. or conv. of deriv. security exemptedFalse825018.13A42269ISee footnotes
Non-Derriv. transCommon Stock2017-05-314M : Exer. or conv. of deriv. security exemptedFalse825018.13A1768543ISee footnotes
Non-Derriv. transCommon Stock2017-05-314M : Exer. or conv. of deriv. security exemptedFalse825018.13A11359212ISee footnotes
Non-Derriv. transCommon Stock2017-05-314M : Exer. or conv. of deriv. security exemptedFalse825018.13A328877ISee footnotes
Non-Derriv. holdingCommon Stock173897ISee footnotes
Derriv. transNon-Qualified Stock Options (right to buy)18.132017-05-314M : Exer. or conv. of deriv. security exemptedFalse82500D2008-06-132017-06-130Common Stock8250ISee Footnotes
Derriv. transNon-Qualified Stock Options (right to buy)18.132017-05-314M : Exer. or conv. of deriv. security exemptedFalse82500D2008-06-132017-06-130Common Stock8250ISee Footnotes
Derriv. transNon-Qualified Stock Options (right to buy)18.132017-05-314M : Exer. or conv. of deriv. security exemptedFalse82500D2008-06-132017-06-130Common Stock8250ISee Footnotes
Derriv. transNon-Qualified Stock Options (right to buy)18.132017-05-314M : Exer. or conv. of deriv. security exemptedFalse82500D2008-06-132017-06-130Common Stock8250ISee Footnotes
Derriv. transNon-Qualified Stock Options (right to buy)18.132017-05-314M : Exer. or conv. of deriv. security exemptedFalse82500D2008-06-132017-06-130Common Stock8250ISee Footnotes
Derriv. transNon-Qualified Stock Options (right to buy)18.132017-05-314M : Exer. or conv. of deriv. security exemptedFalse82500D2008-06-132017-06-130Common Stock8250ISee Footnotes












Filing date
2017-05-31
Submission
 0001638599-17-000511.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 INCYTE CORP  INCY

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Derriv. transNon-Qualified Stock Options (right to buy)134.382017-05-264A : Grant / awardFalse150000A2018-05-262027-05-2515000Common Stock15000ISee Footnotes












Filing date
2017-04-28
Submission
 0001638599-17-000381.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 INCYTE CORP  INCY

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-04-274M : Exer. or conv. of deriv. security exemptedFalse200007.26A4374099ISee Footnote
Non-Derriv. transCommon Stock2017-04-274M : Exer. or conv. of deriv. security exemptedFalse200007.26A29161795ISee Footnote
Non-Derriv. transCommon Stock2017-04-274M : Exer. or conv. of deriv. security exemptedFalse200007.26A787237ISee Footnote
Non-Derriv. holdingCommon Stock58632D
Non-Derriv. holdingCommon Stock61049D
Non-Derriv. holdingCommon Stock33410ISee Footnote
Derriv. transNon-Qualified Stock Options (right7.262017-04-274M : Exer. or conv. of deriv. security exemptedFalse200000D2008-05-222017-05-210Common Stock20000ISee Footnotes
Derriv. transNon-Qualified Stock Options (right7.262017-04-274M : Exer. or conv. of deriv. security exemptedFalse200000D2008-05-222017-05-210Common Stock20000ISee Footnotes
Derriv. transNon-Qualified Stock Options (right7.262017-04-274M : Exer. or conv. of deriv. security exemptedFalse200000D2008-05-222017-05-210Common Stock20000ISee Footnotes












Filing date
2017-04-21
Submission
 0001638599-17-000373.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 BeiGene, Ltd.  BGNE

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Derriv. transShare Option (right to buy)2.842017-04-194A : Grant / awardFalse3999840A2027-04-18399984Ordinary Shares399984ISee Footnotes












Filing date
2017-04-05
Submission
 0001638599-17-000353.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 IDERA PHARMACEUTICALS, INC.  IDRA

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-04-034A : Grant / awardFalse84872.43A1026437ISee footnote
Non-Derriv. transCommon Stock2017-04-034A : Grant / awardFalse84872.43A9331989ISee footnote
Non-Derriv. transCommon Stock2017-04-034A : Grant / awardFalse84872.43A133666ISee footnote












Filing date
2017-04-04
Submission
 0001638599-17-000333.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 GENOMIC HEALTH INC  GHDX

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Investments II, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Investments, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker/Tisch Investments, LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-04-014A : Grant / awardFalse63431.49A214942ISee footnote
Non-Derriv. transCommon Stock2017-04-014A : Grant / awardFalse63431.49A194678ISee footnote
Non-Derriv. transCommon Stock2017-04-014A : Grant / awardFalse63431.49A34019ISee footnote
Non-Derriv. transCommon Stock2017-04-014A : Grant / awardFalse63431.49A1760293ISee footnote
Non-Derriv. transCommon Stock2017-04-014A : Grant / awardFalse63431.49A11350962ISee footnote
Non-Derriv. transCommon Stock2017-04-014A : Grant / awardFalse63431.49A320627ISee footnote
Non-Derriv. holdingCommon Stock173897ISee footnote












Filing date
2017-04-04
Submission
 0001638599-17-000334.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 INCYTE CORP  INCY

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-03-314A : Grant / awardFalse142133.67A4354099ISee Footnote
Non-Derriv. transCommon Stock2017-03-314A : Grant / awardFalse142133.67A29141795ISee Footnote
Non-Derriv. transCommon Stock2017-03-314A : Grant / awardFalse142133.67A767237ISee Footnote
Non-Derriv. holdingCommon Stock58632D
Non-Derriv. holdingCommon Stock61049D
Non-Derriv. holdingCommon Stock33410ISee Footnote












Filing date
2017-02-22
Submission
 0001638599-17-000213.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 INCYTE CORP  INCY

Reporting Owner
 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-02-174A : Grant / awardFalse491338A3851178ISee Footnote
Non-Derriv. transCommon Stock2017-02-174A : Grant / awardFalse502779A4353957ISee Footnote
Non-Derriv. transCommon Stock2017-02-174A : Grant / awardFalse4487412A24245586ISee Footnote
Non-Derriv. transCommon Stock2017-02-174A : Grant / awardFalse4896067A29141653ISee Footnote
Non-Derriv. transCommon Stock2017-02-174A : Grant / awardFalse111514A645423ISee Footnote
Non-Derriv. transCommon Stock2017-02-174A : Grant / awardFalse121672A767095ISee Footnote
Non-Derriv. holdingCommon Stock58632D
Non-Derriv. holdingCommon Stock61049D
Non-Derriv. holdingCommon Stock33410ISee Footnote
Derriv. trans0.375% Convertible Senior Note due 201851.75802017-02-174D : Disp to issuerFalse25000000D2018-11-150Common Stock491338ISee Footnote
Derriv. trans1.25% Convertible Senior Note due 202051.75802017-02-174D : Disp to issuerFalse25000000D2020-11-150Common Stock502779ISee Footnote
Derriv. trans0.375% Convertible Senior Note due 201851.75802017-02-174D : Disp to issuerFalse228326000D2018-11-150Common Stock4487412ISee Footnote
Derriv. trans1.25% Convertible Senior Note due 202051.75802017-02-174D : Disp to issuerFalse243450000D2020-11-150Common Stock4896067ISee Footnote
Derriv. trans0.375% Convertible Senior Note due 201851.75802017-02-174D : Disp to issuerFalse5674000D2018-11-150Common Stock111514ISee Footnote
Derriv. trans1.25% Convertible Senior Note due 202051.75802017-02-174D : Disp to issuerFalse6050000D2020-11-150Common Stock121672ISee Footnote












Filing date
2017-01-05
Submission
 0001638599-17-000048.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 IDERA PHARMACEUTICALS, INC.  IDRA

Reporting Owner
 BAKER JULIAN
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER BROS. ADVISORS LP
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-01-034A : Grant / awardFalse141691.50A1017950ISee footnote
Non-Derriv. transCommon Stock2017-01-034A : Grant / awardFalse141691.50A9323502ISee footnote
Non-Derriv. transCommon Stock2017-01-034A : Grant / awardFalse141691.50A125179ISee footnote












Filing date
2017-01-04
Submission
 0001638599-17-000024.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 INCYTE CORP  INCY

Reporting Owner
 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2016-12-304A : Grant / awardFalse189100.27A3359840ISee Footnote
Non-Derriv. transCommon Stock2016-12-304A : Grant / awardFalse189100.27A19758174ISee Footnote
Non-Derriv. transCommon Stock2016-12-304A : Grant / awardFalse189100.27A533909ISee Footnote
Non-Derriv. holdingCommon Stock58632D
Non-Derriv. holdingCommon Stock61049D
Non-Derriv. holdingCommon Stock33410ISee Footnote












Filing date
2017-01-04
Submission
 0001638599-17-000029.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 GENOMIC HEALTH INC  GHDX

Reporting Owner
 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Investments II, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Investments, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker/Tisch Investments, LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-01-014A : Grant / awardFalse68029.39A214308ISee footnote
Non-Derriv. transCommon Stock2017-01-014A : Grant / awardFalse68029.39A194044ISee footnote
Non-Derriv. transCommon Stock2017-01-014A : Grant / awardFalse68029.39A33385ISee footnote
Non-Derriv. transCommon Stock2017-01-014A : Grant / awardFalse68029.39A1759659ISee footnote
Non-Derriv. transCommon Stock2017-01-014A : Grant / awardFalse68029.39A11350328ISee footnote
Non-Derriv. transCommon Stock2017-01-014A : Grant / awardFalse68029.39A319993ISee footnote
Non-Derriv. holdingCommon Stock173897ISee footnote












Filing date
2016-11-21
Submission
 0001638599-16-001591.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 BeiGene, Ltd.  BGNE

Reporting Owner
 BAKER BROS. ADVISORS LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER JULIAN
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				        10% owner, 
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transAmerican Depositary Shares2016-11-184P : Open market or private purchaseFalse16582432.00A355198ISee Footnotes
Non-Derriv. transAmerican Depositary Shares2016-11-184P : Open market or private purchaseFalse159467132.00A3317977ISee Footnotes
Non-Derriv. holdingOrdinary shares6533135ISee Footnotes
Non-Derriv. holdingOrdinary shares73162022ISee Footnotes
Non-Derriv. holdingOrdinary shares639600ISee Footnotes












Filing date
2016-10-11
Submission
 0001638599-16-001463.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 IDERA PHARMACEUTICALS, INC.  IDRA

Reporting Owner
 BAKER JULIAN
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Bros. Advisors (GP) LLC
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER BROS. ADVISORS LP
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 Baker Brothers Life Sciences LP
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 14159, L.P.
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 BAKER FELIX
[
				      
				        Director,  
				      
				      
				      
				      
				      ]

 667, L.P.
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2016-10-074P : Open market or private purchaseFalse3214042.00A1003781ISee footnote
Non-Derriv. transCommon Stock2016-10-074P : Open market or private purchaseFalse29285962.00A9309333ISee footnote
Non-Derriv. holdingCommon Stock111010ISee footnote









←


 1 


 2 


 3 


 4 


 5 


→


 







db
 
 


















































































14159, L.P. - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











14159, L.P.
Check out list of companies and businesses related to 14159, L.P.. Find out 14159, L.P. address and contact details. View other people related to 14159, L.P. - coworkers, colleagues, companions, etc.
Address:   

667 MADISION AVENUE, 21ST FLOOR  NEW YORK US 10065 NY




Companies related to 14159, L.P.
CIKCompany NamePositionCompany Address0000791908XOMA Corp2910 SEVENTH ST  BERKELEY 947100000861838IDERA PHARMACEUTICALS, INC.167 SIDNEY STREET  CAMBRIDGE 021390000879169INCYTE CORP1801 AUGUSTINE CUT-OFF  WILMINGTON 198030000882796BIOCRYST PHARMACEUTICALS INC4505 EMPEROR BOULEVARD SUITE 200 DURHAM 277030000911326SYNAGEVA BIOPHARMA CORP33 HAYDEN AVE.  LEXINGTON 024210001060736SEATTLE GENETICS INC /WA21823 30TH DRIVE SE SUITE BOTHELL 980210001070494ACADIA PHARMACEUTICALS INCDirector 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO 921300001131324GENOMIC HEALTH INC301 PENOBSCOT DRIVE  REDWOOD CITY 940630001651308BeiGene, Ltd.C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN KY1-1108




14159, L.P. on the Web
Persons related to 14159, L.P. - XOMA CorpNamePositionCity14159 capital (GP), LLCNEW YORK667, L.P.NEW YORKJAMES G  ANDRESSJAMES G  ANDRESSDirector LAKE FORESTJAMES G  ANDRESSDirector BERKELEYBaker Biotech Capital (GP), LLCNEW YORKBaker Bros. Advisors (GP) LLCNEW YORKBAKER BROS ADVISORS LLC NEW YORKBAKER BROS ADVISORS LLCDirector NEW YORKBAKER BROS. ADVISORS LPDirector NEW YORKBaker Brothers Life Sciences Capital (GP), LLCNEW YORKBaker Brothers Life Sciences LPNEW YORKFELIX  BAKERFELIX  BAKERNEW YORKJULIAN  BAKERJULIAN  BAKERDirector NEW YORKBIOTECHNOLOGY VALUE FUND II LPBIOTECHNOLOGY VALUE FUND L PBiotechnology Value Trading Fund OS LPGRAND CAYMANWILLIAM K  BOWES JRDirector WILLIAM K  BOWES JRDirector MENLO PARKWILLIAM K  BOWES JRDirector MENLO PARKWILLIAM K  BOWES JRDirector BERKELEYWILLIAM K  BOWES JRDirector BERKELEYJ DAVID  BOYLE IIVP, Finance, and CFO BERKELEYJ DAVID  BOYLE IIVP, Finance, and CFO BERKELEYTHOMAS M.  BURNSVP, Finance & CFO BERKELEYBVF INC/ILBVF PARTNERS L P/ILBVF Partners OS Ltd.GRAND CAYMANJOHN L  CASTELLOPresident, CEO and BERKELEYJOHN L  CASTELLOPresident, CEO and BERKELEYPETER B  DAVISPETER B  DAVISVP, Finance & CFO BERKELEYCLARENCE L  DELLIOSr VP, Operations and COO STEVEN B  ENGLEChairman, CEO & President BERKELEYCHARLES J  FISHER JRDirector BERKELEYPETER BARTON  HUTTDirector IRVINEPETER BARTON  HUTTDirector BERKELEYPETER BARTON  HUTTDirector BERKELEYPETER BARTON  HUTTThomas  KleinChief Commercial Officer BERKELEYARTHUR MD  KORNBERGDirector ARTHUR MD  KORNBERGDirector BERKELEYFRED  KURLANDCFO & VP Finance MENLO PARKFRED  KURLANDCFO & VP Finance BERKELEYFRED  KURLANDCFO & VP Finance BERKELEYMARK N  LAMPERTSAN FRANCISCOJOSEPH M  LIMBERDirector WATERTOWNJOSEPH M  LIMBERDirector BERKELEYCHRISTOPHER J  MARGOLINVP, General Counsel & Sec'y BERKELEYCHRISTOPHER J  MARGOLINVP, General Counsel & Sec'y BERKELEYCHRISTOPHER J  MARGOLINBERKELEYSTEVEN C  MENDELLSTEVEN C  MENDELLDirector BERKELEYJames R  NealCEO BERKELEYKelvin  NeuDirector BERKELEYMATTHEW D  PERRYDirector SAN FRANCISCOPAUL D  RUBINSr. VP Clinical Dev. & CMO LEXINGTONPAUL D  RUBINVP Clinical Dev. & CMO BERKELEYPAUL D  RUBINSr. VP Clinical Dev. & CMO BERKELEYPATRICK J MD PHD  SCANNONExec. VP & CSO BERKELEYPATRICK J MD PHD  SCANNONExecutive Vice President BERKELEYPATRICK J MD PHD  SCANNONExec. VP & CSO BERKELEYNESS W DENMAN  VANDirector NESS W DENMAN  VANDirector BERKELEYNESS W DENMAN  VANDirector BERKELEYNESS W DENMAN  VANDirector BERKELEYJohn  VarianDirector FREMONTJohn  VarianDirector & Interim CEO BERKELEYJohn  VarianCEO BERKELEYTimothy P  WalbertDirector WAUKEGANTimothy P  WalbertDirector BERKELEYTimothy P  WalbertDirector BERKELEYJACK L  WYSZOMIERSKIDirector KENILWORTHJACK L  WYSZOMIERSKIDirector BERKELEYJACK L  WYSZOMIERSKIDirector NEW HOPEJACK L  WYSZOMIERSKIDirector BERKELEYPATRICK J  ZENNERPATRICK J  ZENNERDirector BEDMINSTERPATRICK J  ZENNERDirector BERKELEYPATRICK J  ZENNERDirector MORRISTOWNPersons related to 14159, L.P. - IDERA PHARMACEUTICALS, INC.NamePositionCity14159 capital (GP), LLCNEW YORK14159 capital (GP), LLC10% Owner NEW YORK667, L.P.NEW YORKUmari  Abdul-WahabBEIRUTUmari  Abdul-WahabBEIRUTSUDHIR  AGRAWALPresident of Research CAMBRIDGESUDHIR  AGRAWALCEO & CSO CAMBRIDGESUDHIR  AGRAWALPresident of Research CAMBRIDGESUDHIR  AGRAWALCAMBRIDGETaunton-Rigby  AlisonDirector LINCOLNROBERT G  ANDERSENCFO & VP Oper. and Planning CAMBRIDGEROBERT G  ANDERSENCFO & VP Oper. and Planning CAMBRIDGERobert D.  ArbeitVP Clinical Development CAMBRIDGERobert D.  ArbeitVP Clinical Development CAMBRIDGELouis J  Arcudi IIIChief Financial Officer CAMBRIDGELouis J.  ArcudiChief Financial Officer CAMBRIDGEBaker Biotech Capital (GP), LLCNEW YORKBaker Biotech Capital (GP), LLC10% Owner NEW YORKBaker Biotech Capital II (GP), LLCNEW YORKBaker Biotech Capital II (Z) (GP), LLCNEW YORKBaker Biotech Capital II (Z) (GP), LLCNEW YORKBaker Biotech Capital III (GP), LLCNEW YORKBaker Biotech Capital III (GP), LLCNEW YORKBaker Biotech Capital III (Z) (GP), LLCNEW YORKBaker Biotech Capital III (Z) (GP), LLCNEW YORKBaker Bros. Advisors (GP) LLCNEW YORKBAKER BROS ADVISORS LLCDirector NEW YORKBAKER BROS. ADVISORS LPNEW YORKBaker Bros. Capital (GP), LLCNEW YORKBaker Bros. Capital (GP), LLC10% Owner NEW YORKBaker Brothers Life Sciences Capital (GP), LLC10% Owner NEW YORKBaker Brothers Life Sciences Capital (GP), LLCNEW YORKBaker Brothers Life Sciences Capital (GP), LLC10% Owner NEW YORKBaker Brothers Life Sciences LPNEW YORKFELIX  BAKERFELIX  BAKERNEW YORKFELIX  BAKERNEW YORKFELIX  BAKERNEW YORKJULIAN  BAKERDirector JULIAN  BAKERNEW YORKJULIAN  BAKERDirector NEW YORKJULIAN  BAKERNEW YORKAlice  BexonCAMBRIDGEAlice  BexonV.P. Clinical Development CAMBRIDGELOUIS MD  BRENNERChief Medical Officer CAMBRIDGEMark J  CaseySenior VP & General Counsel MARLBOROUGHRobert C.  FletcherSr. VP, Bus. Dev. & Strategy EXTONRobert C.  FletcherSr. VP, Bus. Dev. & Strategy CAMBRIDGEJAMES A  GERAGHTYDirector FRAMINGHAMJAMES A  GERAGHTYDirector CAMBRIDGEMark Alan  GoldbergDirector NEEDHAMMark Alan  GoldbergDirector CAMBRIDGEMAXINE  GOWENDirector W. CONSHOHOCKENC KEITH  HARTLEYDirector GREENWICHJoanna  HorobinChief Medical Officer CAMBRIDGERobert W  KarrDirector ESSEXRobert W  KarrDirector ST. LOUISMalcolm  MacCossDirector SEABROOK ISLANDRUSSELL  MARTINSenior VP of Drug Development CAMBRIDGEVINCENT  MILANOPresident & CEO VINCENT  MILANOPresident and CEO CAMBRIDGEHANS  MUELLERDirector WEST CHESTERKelvin  NeuBERKELEYPillar Invest CorpDirector BEIRUTPillar Invest CorpDirector CAMBRIDGEPillar Pharmaceuticals I LPBEIRUTPillar Pharmaceuticals I LPBEIRUTPillar Pharmaceuticals I LPDirector BEIRUTPillar Pharmaceuticals I LPBEIRUTPillar Pharmaceuticals I LPBEIRUTPillar Pharmaceuticals II, L.P.BEIRUTPillar Pharmaceuticals II, L.P.BEIRUTPillar Pharmaceuticals II, L.P.BEIRUTPillar Pharmaceuticals III, L.P.BEIRUTPillar Pharmaceuticals IV, L.P.BEIRUTPillar Pharmaceuticals V LPBEIRUTWILLIAM S  REARDONDirector HINGHAMALISON TAUNTON  RIGBYDirector LINCOLNSenator Investment Group LPNEW YORKSenator Investment Group LP10% Owner NEW YORKEve Elizabeth  SlaterDirector CAMBRIDGEEve Elizabeth  SlaterDirector SHORT HILLSTimothy M  SullivanVP Development Programs CAMBRIDGETimothy M  SullivanVP Development Programs CAMBRIDGEJohn Peter  Wolf IIIGeneral Counsel CAMBRIDGEJAMES B  WYNGAARDENDirector DURHAMJAMES B  WYNGAARDENDirector DURHAMJONATHAN MICHAEL  YINGLINGSVP of Early Development CAMBRIDGEPAUL C  ZAMECNIKDirector BOSTONYOUSSEF EL  ZEINDirector CAMBRIDGEYOUSSEF EL  ZEINDirector CAMBRIDGEYOUSSEF EL  ZEINDirector CAMBRIDGEYOUSSEF EL  ZEINBEIRUTYOUSSEF EL  ZEINBEIRUTYOUSSEF EL  ZEINBEIRUTYOUSSEF EL  ZEINBEIRUTPersons related to 14159, L.P. - INCYTE CORPNamePositionCity14159 capital (GP), LLCDirector NEW YORK,14159 capital (GP), LLCDirector NEW YORK14159 capital (GP), LLCDirector NEW YORK667, L.P.NEW YORKPatricia S  AndrewsChief Commercial Officer WILMINGTONBARRY A  ARIKODirector SAN JOSEBARRY A  ARIKODirector WILMINGTONBARRY A  ARIKODirector WILMINGTONBARRY A  ARIKODirector WILMINGTONBAKER BIOTECH CAPITAL GP LLCNEW YORKBAKER BIOTECH CAPITAL GP LLCNEW YORKBaker Biotech Capital (GP), LLCDirector NEW YORKBaker Biotech Capital (GP), LLCDirector NEW YORKBAKER BIOTECH CAPITAL II GP LLCNEW YORKBAKER BIOTECH CAPITAL II GP LLCNEW YORKBaker Bros. Advisors (GP) LLCNEW YORKBAKER BROS ADVISORS LLCDirector NEW YORKBAKER BROS ADVISORS LLCNEW YORKBAKER BROS. ADVISORS LPNEW YORKBaker Bros. Capital (GP), LLCDirector NEW YORKBaker Bros. Capital (GP), LLCDirector NEW YORK,Baker Bros. Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences LPNEW YORKFELIX  BAKERFELIX  BAKERNEW YORK,FELIX  BAKERNEW YORKFELIX  BAKERNEW YORK,FELIX  BAKERNEW YORKFELIX  BAKERNEW YORKFELIX  BAKERNEW YORKJULIAN  BAKERDirector JULIAN  BAKERDirector NEW YORKJULIAN  BAKERNEW YORK,JULIAN  BAKERNEW YORKJULIAN  BAKERNEW YORK,JULIAN  BAKERNEW YORKJULIAN  BAKERDirector NEW YORKJULIAN  BAKERDirector NEW YORKBaker / Tisch Capital (GP), LLCDirector NEW YORKBaker / Tisch Capital (GP), LLCDirector NEW YORKJEAN JACQUES  BIENAIMEDirector JEAN JACQUES  BIENAIMEDirector WILMINGTONPAUL A  BROOKEDirector WILMINGTONPAUL A  BROOKEWILMINGTONPAUL A  BROOKEDirector WILMINGTONPAUL A  BROOKEDirector WILMINGTONLaurent  ChardonnetVP Finance and Treasurer WILMINGTONLaurent  Chardonnet WILMINGTONPaul J  ClancyDirector CAMBRIDGEPaul J  ClancyDirector WILMINGTONFRED B  CRAVESDirector SAN FRANCISCOFRED B  CRAVESDirector WILMINGTONFRED B  CRAVESDirector WILMINGTONJames M  DalyEVP, Chief Commercial Officer WILMINGTONJames M  DalyEVP, Chief Commercial Officer WILMINGTONJames M  DalyEVP, Chief Commercial Officer WILMINGTONDAMIAL FOUNDATION INCNEW YORKSCHUTTER RICHARD U  DEDirector PALO ALTOSCHUTTER RICHARD U  DEDirector WILMINGTONSCHUTTER RICHARD U  DEDirector WILMINGTONSCHUTTER RICHARD U  DEWILMINGTONSCHUTTER RICHARD U  DEDirector WILMINGTONSCHUTTER RICHARD U  DEDirector WILMINGTONWENDY L  DIXONDirector PRINCETONMatthew  EmmensDirector WILMINGTONMatthew  EmmensWILMINGTONAssociates  FBBNEW YORKFBB2 LLCNEW YORKBarry P  FlannellyEVP & General Manager US WILMINGTONBarry P  FlannellyEVP, Business Development WILMINGTONPAUL A  FRIEDMANDirector PALO ALTOPAUL A  FRIEDMANDirector WILMINGTONPAUL A  FRIEDMANChief Executive Officer WILMINGTONPAUL A  FRIEDMANChief Executive Officer WILMINGTONPAUL A  FRIEDMANDirector WILMINGTONSteven M.  FriedmanEVP, Biology & Preclinical Dev WILMINGTONDAVID W  GRYSKAExecutive Vice President, CFO SOUTH SAN FRANCISCODAVID W  GRYSKAExecutive Vice President, CFO WILMINGTONDAVID C  HASTINGSExec VP & CFO PALO ALTODAVID C  HASTINGSExec VP & CFO WILMINGTONDAVID C  HASTINGSChief Financial Officer WILMINGTONHerve  HoppenotChairman / CEO WILMINGTONHerve  HoppenotChief Executive Officer WILMINGTONReid M  HuberEVP, Chief Scientific Officer WILMINGTONReid M  HuberEVP, Chief Scientific Officer WILMINGTONSCOTT W  HURLEY PALO ALTOSCOTT W  HURLEY WILMINGTONVijay K  IyengarEVP GPS, BD, & Licensing WILMINGTONJOHN A  KELLERExec VP & Chief Bus Officer PALO ALTOJOHN A  KELLERExec VP & Chief Bus Officer WILMINGTONJOHN A  KELLERChief Business Officer WILMINGTONRichard S  LevyEVP, Chief Drug Dev Officer WILMINGTONRichard S  LevyEVP, Chief Drug Dev&Medical Of WILMINGTONBRIAN W  METCALF PALO ALTOBRIAN W  METCALF WILMINGTONBRIAN W  METCALFChief Drug Discovery Scientist WILMINGTONJOHN F  NIBLACKDirector WILMINGTONJOHN F  NIBLACKDirector WILMINGTONPLATINUM ASSET MANAGEMENT LTDSYDNEYJON S  SAXEDirector PALO ALTOPATRICIA A  SCHRECKPALO ALTOPATRICIA A  SCHRECKEVP and General Counsel WILMINGTONPATRICIA A  SCHRECKEVP, General Counsel WILMINGTONEric H.  SiegelEVP, General Counsel WILMINGTONEric H.  SiegelEVP, General Counsel WILMINGTONSteven H  SteinEVP & Chief Medical Officer WILMINGTONPAULA J  SWAINEVP, Human Resources PALO ALTOPAULA J  SWAIN WILMINGTONPAULA J  SWAINEVP, Human Resources WILMINGTONPAULA J  SWAINEVP, Human Resources WILMINGTONANDREW H  TISCH10% Owner NEW YORKDANIEL R  TISCH10% Owner NEW YORKJAMES S  TISCH10% Owner NEW YORKTHOMAS J  TISCH10% Owner NEW YORKPaul  TrowerPrincipal Accounting Officer WILMINGTONYao  WenqingEVP, Head of Discovery Chem WILMINGTONROY A  WHITFIELDDirector WILMINGTONROY A  WHITFIELDDirector WILMINGTONPersons related to 14159, L.P. - BIOCRYST PHARMACEUTICALS INCNamePositionCity14159 capital (GP), LLC10% Owner NEW YORK667, L.P.NEW YORKGEORGE B  ABERCROMBIEDirector DURHAMGEORGE B  ABERCROMBIEDirector CHAPEL HILLGEORGE B  ABERCROMBIEDirector CHAPEL HILLW JAMES  ALEXANDERSR. VP, Chief Medical Officer BIRMINGHAMYarlagadda S  BabuSenior VP - Drug Discovery BIRMINGHAMYarlagadda S  BabuSenior VP - Drug Discovery DURHAMBaker Biotech Capital (GP), LLC10% Owner NEW YORKBaker Bros. Advisors (GP) LLCNEW YORKBAKER BROS ADVISORS LLC10% Owner NEW YORKBAKER BROS. ADVISORS LPNEW YORKBaker Bros. Capital (GP), LLC10% Owner NEW YORKBaker Bros. Capital (GP), LLC10% Owner NEW YORKBaker Bros. Investments II, L.P.NEW YORKBaker Bros. Investments, L.P.NEW YORKBaker Brothers Life Sciences Capital (GP), LLC10% Owner NEW YORKBaker Brothers Life Sciences Capital (GP), LLC10% Owner NEW YORKBaker Brothers Life Sciences LPNEW YORKFELIX  BAKERFELIX  BAKER10% Owner NEW YORKFELIX  BAKERNEW YORKJULIAN  BAKERJULIAN  BAKERNEW YORKJULIAN  BAKERNEW YORKBaker / Tisch Capital (GP), LLC10% Owner NEW YORKBaker/Tisch Investments, LPNEW YORKAlane P  BarnesVP, General Counsel & Corp Sec RALEIGHAlane P  BarnesVP, General Counsel & Corp Sec DURHAMJ CLAUDE  BENNETTPresident BIRMINGHAMJ CLAUDE  BENNETTPresident BIRMINGHAMJ CLAUDE  BENNETTChief Operating Officer BIRMINGHAMStephen R  BiggarDirector BIRMINGHAMStephen R  BiggarDirector DURHAMCHARLES E  BUGGCEO, Chairman BIRMINGHAMCHARLES E  BUGGCEO BIRMINGHAMCHARLES E  BUGGDirector BIRMINGHAMFred E  CohenDirector SAN FRANCISCOFred E  CohenDirector FORT WORTHMICHAEL A  DARWINCFO BIRMINGHAMMICHAEL A  DARWINCFO 2190 PARKWAY LAKE DRMICHAEL A  DARWINPrincipal Accounting Officer BIRMINGHAMStanley C  ErckDirector GAITHERSBURGStanley C  ErckDirector BIRMINGHAMStanley C  ErckDirector DURHAMWILLIAM W  FEATHERINGILLDirector BIRMINGHAMWILLIAM W  FEATHERINGILLDirector BIRMINGHAMWILLIAM W  FEATHERINGILLDirector BIRMINGHAMCARL L  GORDONNEW YORKCARL L  GORDONNEW YORKCARL L  GORDONDirector BIRMINGHAM,CARL L  GORDONDirector BIRMINGHAMStuart  GrantSR VP & CFO BIRMINGHAMJOHN L  HIGGINSDirector DURHAMJOHN L  HIGGINSDirector BIRMINGHAMJOHN L  HIGGINSDirector BIMRINGHAMJOHN L  HIGGINSDirector BIRMINGHAMZOLA P  HOROVITZDirector BIRMINGHAMZOLA P  HOROVITZDirector DURHAMZOLA P  HOROVITZDirector BIRMINGHAMNancy J  HutsonDirector DURHAMNancy J  HutsonDirector STONINGTONROBERT A  INGRAMDirector Peder  JensenDirector DURHAMKENNETH B  LEE JRDirector KENNETH B  LEE JRDirector DURHAMROBERT S  LOWREYController, PAO DURHAMDavid  McCulloughVP BIRMINGHAMDavid  McCulloughVP DURHAMMike  MillsPrincipal Accounting Officer BIRMINGHAMJonathan M  NugentVP Corp Communications BIRMINGHAMJonathan M  NugentVP Corp Communications BIRMINGHAMSanj K  PatelDirector LEXINGTONLynne  PowellSenior VP - CCO DURHAMRANDALL B  RIGGSVP Business Development BIRMINGHAMRANDALL B  RIGGSSenior VP Business Development BIRMINGHAMCHARLES A  SANDERSDirector CHARLES A  SANDERSDirector BIRMINGHAMCHARLES A  SANDERSDirector DURHAMBETH C  SEIDENBERGDirector BIRMINGHAMWilliam P  SheridanSenior VP - CMO BIRMINGHAMWilliam P  SheridanSenior VP - CMO DURHAMJOSEPH H  SHERRILL JRDirector BIRMINGHAMJOSEPH H  SHERRILL JRDirector BIRMINGHAMWILLIAM M  SPENCER IIIDirector BIRMINGHAMWILLIAM M  SPENCER IIIDirector BIRMINGHAMTHOMAS R  STAAB IISenior Vice President and CFO DURHAMTHOMAS R  STAAB IISenior Vice President and CFO DURHAMRANDOLPH C  STEERDirector BIRMINGHAMRANDOLPH C  STEERDirector BIRMINGHAMJon P  StonehousePresident & CEO BIRMINGHAMJon P  StonehousePresident & CEO DURHAMPersons related to 14159, L.P. - SYNAGEVA BIOPHARMA CORPNamePositionCity14159 capital (GP), LLCDirector NEW YORK14159 capital (GP), LLCDirector NEW YORK667, L.P.NEW YORKSRINIVAS  AKKARAJUDirector MENLO PARKSRINIVAS  AKKARAJULEXINGTONALEXION PHARMACEUTICALS INCCHESHIREMichael A  AlrutzGeneral Counsel MORRISVILLEMichael A  AlrutzGeneral Counsel DURHAMBaker Biotech Capital (GP), LLCDirector NEW YORKBAKER BIOTECH CAPITAL GP LLCDirector NEW YORKBaker Biotech Capital II (A) (GP), LLCNEW YORKBAKER BIOTECH CAPITAL II GP LLCDirector NEW YORKBaker Biotech Capital II (GP), LLCNEW YORKBaker Biotech Capital II (Z) (GP), LLCNEW YORKBaker Biotech Capital II (Z) (GP), LLCNEW YORKBaker Biotech Fund II (A), L.P.NEW YORKBaker Bros. Advisors (GP) LLCNEW YORKBAKER BROS ADVISORS LLCNEW YORKBAKER BROS ADVISORS LLCNEW YORKBAKER BROS. ADVISORS LPNEW YORKBAKER BROS CAPITAL GP LLCDirector NEW YORKBaker Bros. Capital (GP), LLCDirector NEW YORKBaker Bros. Capital (GP), LLCDirector NEW YORKBaker Bros. Investments II, L.P.NEW YORKBaker Bros. Investments, L.P.NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences LPNEW YORKFELIX  BAKERDirector FELIX  BAKERDirector NEW YORKFELIX  BAKERDirector NEW YORKFELIX  BAKERNEW YORKFELIX  BAKERDirector NEW YORKFELIX  BAKERDirector NEW YORKFELIX  BAKERDirector NEW YORKJULIAN  BAKERDirector JULIAN  BAKERDirector NEW YORKJULIAN  BAKERDirector NEW YORKJULIAN  BAKERDirector NEW YORKJULIAN  BAKERDirector NEW YORKJULIAN  BAKERDirector NEW YORKBAKER TISCH CAPITAL GP LLCDirector NEW YORKBaker / Tisch Capital (GP), LLCDirector NEW YORKBaker / Tisch Capital (GP), LLCDirector NEW YORKBaker/Tisch Investments, LPNEW YORKRobert B  BazemoreChief Operating Officer LEXINGTONStephen R  Biggar BIRMINGHAMStephen R  BiggarLEXINGTONStephen R  BiggarDirector LEXINGTONCARSTEN  BOESSSVP, Chief Financial Officer CHESHIRECARSTEN  BOESSLEXINGTONCARSTEN  BOESSSVP, Chief Financial Officer LEXINGTONCARSTEN  BOESSSVP, Chief Financial Officer LEXINGTONDANI P  BOLOGNESIDANI P  BOLOGNESIChief Scientific Officer DURHAMDANI P  BOLOGNESIDirector MORRISVILLEROBERT R  BONCZEKROBERT R  BONCZEKCFO and General Counsel DURHAMROBERT R  BONCZEKCFO and General Counsel MORRISVILLEBRIDGER CAPITAL LLCNEW YORKBRIDGER CAPITAL LLCNEW YORKBRIDGER MANAGEMENT LLC10% Owner NEW YORKBRIDGER MANAGEMENT LLC10% Owner NEW YORKArthur Bruce  CohenNEW YORKArthur Bruce  CohenNEW YORKArthur Bruce  CohenNORWALKArthur Bruce  CohenNORWALKArthur Bruce  CohenNEW YORKArthur Bruce  CohenNORWALKGARY  COOKGARY  COOKDirector DURHAMGARY  COOKDirector MORRISVILLETIMOTHY J  CREECHTIMOTHY J  CREECHVice President of Finance DURHAMJ RICHARD  CROUTJ RICHARD  CROUTDirector DURHAMJ RICHARD  CROUTDirector MORRISVILLESTEPHEN  DAVISDirector BRANFORDSTEPHEN  DAVIS LEXINGTONSTEPHEN  DAVISDirector MORRISVILLESTEPHEN  DAVISDirector DURHAMSTEPHEN  DAVISDirector LEXINGTONSTEPHEN  DAVIS LEXINGTONJOSEPH  EDELMANNEW YORKM NIXON  ELLISM NIXON  ELLISPresident DURHAMAssociates  FBBNEW YORKMichael  GlynnLEXINGTONMichael  GlynnSVP, Global Commercial Ops. LEXINGTONMark Alan  GoldbergSVP,Medical&Regulatory Affairs LEXINGTONMark Alan  GoldbergEVP, Medical & Reg. Strategy LEXINGTONAndrew L  GrahamDURHAMAndrew L  GrahamChief Financial Officer MORRISVILLEAndrew L  GrahamChief Financial Officer DURHAMEric  GrinsteadLEXINGTONEric  GrinsteadSVP, Commercial Operations LEXINGTONJoseph Patrick  HealeyNEW YORKJoseph Patrick  HealeyNEW YORKJoseph Patrick  HealeyNEW YORKHealthCor Associates, LLCNEW YORKHealthCor Associates, LLCNEW YORKHealthCor Capital, L.P.NEW YORKHealthCor Group, LLCNEW YORKHybrid Offshore  HealthCorNEW YORKHealthCor Hybrid Offshore GP, LLCNEW YORKHealthCor Hybrid Offshore GP, LLCNEW YORKHealthCor Hybrid Offshore Master Fund, L.P.NEW YORKHealthCor Hybrid Offshore Master Fund, L.P.NEW YORKHEALTHCOR L PNEW YORKHEALTHCOR L PNEW YORKHealthCor Management, L.P.Director NEW YORKHealthCor Management, L.P.10% Owner NEW YORKHealthCor Management, L.P.Director NEW YORKHealthCor Offshore GP, LLCDirector NEW YORKHealthCor Offshore GP, LLCNEW YORKHealthCor Offshore, Ltd.NEW YORKHealthCor Offshore, Ltd.NEW YORKHealthCor Offshore, Ltd.NEW YORKHealthCor Offshore, Ltd.NEW YORKHealthCor Offshore Master Fund, L.P.NEW YORKHealthCor Offshore Master Fund, L.P.NEW YORKHealthCor Strategic, LLCNEW YORKChris  HeberligSVP, Finance & Business Ops. LEXINGTONChris  HeberligVice President, Finance LEXINGTONChris  HeberligGroup Vice President, Finance LEXINGTONE LAWRENCE  HILL JRMORRISVILLEGeorge W  Koszalka DURHAMJEFFREY M  LIPTONJEFFREY M  LIPTONDirector DURHAMJEFFREY M  LIPTONDirector MORRISVILLEThomas  MalleyDirector DENVERThomas  Malley LEXINGTONThomas  Malley LEXINGTONMARTIN A  MATTINGLYChief Executive Officer MORRISVILLEMARTIN A  MATTINGLYChief Executive Officer DURHAMROBERTO  MIGNONENEW YORKROBERTO  MIGNONENEW YORKCarol  Ohmstede MORRISVILLESanj K  PatelPresident & CEO LEXINGTONSanj K  PatelPresident & CEO LEXINGTONSanj K  PatelPresident & CEO LEXINGTONPERCEPTIVE ADVISORS LLC10% Owner NEW YORKPulsar Merger Sub IncCHESHIREBarry D  QuartDirector LAFAYETTEBarry D  QuartDirector MORRISVILLEBarry D  QuartDirector DURHAMBarry D  QuartDirector LEXINGTONBarry D  Quart LEXINGTONBarry D  Quart LEXINGTONAnthony  QuinnEVP, CMO, & Head of R&D LEXINGTONAnthony  QuinnSVP, Chief Medical Officer LEXINGTONAnthony  QuinnEVP, CMO & Head of R&D LEXINGTONDaniel  RattoMORRISVILLLERobyn  SamuelsLEXINGTONRobyn  SamuelsDirector LEXINGTONCHARLES A  SANDERSCHARLES A  SANDERSDirector DURHAMCHARLES A  SANDERSDirector MORRISVILLEAlicia  SecorSVP, Chief Operating Officer LEXINGTONSteven D  SkolskyChief Executive Officer DURHAMSteven D  SkolskyChief Executive Officer MORRISVILLESWIFTCURRENT OFFSHORE LTDNEW YORKSWIFTCURRENT OFFSHORE LTD.NEW YORKPARTNERS  SWIFTCURRENTNEW YORKSWIFTCURRENT PARTNERS, L.P.NEW YORKKEVIN C  TANGKEVIN C  TANGDirector SAN DIEGOKEVIN C  TANGDirector DURHAMKEVIN C  TANGDirector MORRISVILLEKEVIN C  TANGDirector DURHAMJames R  ThomasChief Financial Officer DURHAMANDREW H  TISCHNEW YORKDANIEL R  TISCH10% Owner NEW YORKJAMES S  TISCHNEW YORKTHOMAS J  TISCHDirector FAIRFAXTHOMAS J  TISCHDirector NEW YORKTHOMAS J  TISCH LEXINGTONTHOMAS J  TISCHDirector NEW YORKGlen  WilliamsSVP, Technical Operations LEXINGTONGlen  WilliamsSVP, Technical Operations LEXINGTONPETER  WIRTHDirector PETER  WIRTH LEXINGTONPETER  WIRTH LEXINGTONPersons related to 14159, L.P. - SEATTLE GENETICS INC /WANamePositionCity14159 Capital (GP, LLCDirector NEW YORK14159 capital (GP), LLCDirector NEW YORK14159 capital (GP), LLCDirector NEW YORK14159 capital (GP), LLCDirector NEW YORK14159 capital (GP), LLCDirector NEW YORK14159 capital (GP), LLCDirector NEW YORK14159 capital (GP), LLCDirector NEW YORK14159 capital (GP), LLCDirector NEW YORK14159 capital (GP), LLCDirector NEW YORK667, L.P.NEW YORKSRINIVAS  AKKARAJUDirector SRINIVAS  AKKARAJUDirector MENLO PARKSRINIVAS  AKKARAJUDirector MENLO PARKSRINIVAS  AKKARAJUDirector MENLO PARKSRINIVAS  AKKARAJUDirector BOTHELLSRINIVAS  AKKARAJUDirector NEW YORKSRINIVAS  AKKARAJUDirector NEW YORKBaker Biotech Capital (GP), LLCDirector NEW YORKBAKER BIOTECH CAPITAL GP LLCDirector NEW YORKBaker Biotech Capital (GP), LLCDirector NEW YORKBaker Biotech Capital (GP), LLCDirector NEW YORKBaker Biotech Capital (GP), LLCDirector NEW YORKBaker Biotech Capital (GP), LLCDirector NEW YORKBAKER BIOTECH CAPITAL II GP LLCDirector NEW YORKBaker Biotech Capital II (GP), LLCDirector NEW YORKBaker Biotech Capital II (GP), LLCNEW YORKBaker Biotech Capital II (Z) (GP), LLCDirector NEW YORKBaker Biotech Capital II (Z) (GP), LLCDirector NEW YORKBaker Biotech Capital III (GP), LLCDirector NEW YORKBaker Biotech Capital III (GP), LLCDirector NEW YORKBaker Biotech Capital III (Z) (GP), LLCDirector NEW YORKBaker Biotech Capital III (Z) (GP), LLCDirector NEW YORKBaker Bros. Advisors (GP) LLCNEW YORKBAKER BROS ADVISORS LLCDirector NEW YORKBAKER BROS ADVISORS LLCNEW YORKBAKER BROS. ADVISORS LPNEW YORKBAKER BROS CAPITAL GP LLCDirector NEW YORKBaker Bros. Capital (GP), LLCDirector NEW YORKBaker Bros. Capital (GP), LLCDirector NEW YORKBaker Bros. Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences LPNEW YORKFELIX  BAKERDirector FELIX  BAKERDirector NEW YORKFELIX  BAKERDirector NEW YORKFELIX  BAKERDirector NEW YORKJULIAN  BAKERJULIAN  BAKERNEW YORKJULIAN  BAKERNEW YORKJULIAN  BAKERNEW YORKJULIAN  BAKERNEW YORKBAKER TISCH CAPITAL GP LLCDirector NEW YORKBaker / Tisch Capital (GP), LLCDirector NEW YORKBaker / Tisch Capital (GP), LLCDirector NEW YORKBaker / Tisch Capital (GP), LLCDirector NEW YORKFRANKLIN M  BERGERDirector BOTHELLFRANKLIN M  BERGERDirector SE BOTHELLCHRISTOPHER S.  BOERNERExecutive Vice President, Comm BOTHELLTIM  CARROLLCFO BOTHELLCASCADE INVESTMENT LLCKIRKLANDSiegall  ClayBothellDarren S  ClineEVP, Commercial BOTHELLHoth  DanielBothellWelch  DanielBothellGryska  DavidBothellDELPHI BIOINVESTMENTS VI LPMENLO PARKDELPHI MANAGEMENT PARTNERS VI LLCMENLO PARK,DELPHI MANAGEMENT PARTNERS VI LLC10% Owner MENLO PARKDELPHI VENTURES VI LPMENLO PARK,DELPHI VENTURES VI LPMENLO PARKERIC  DOBMEIERChief Operating Officer BOTHELLJONATHAN G  DRACHMANCMO & EVP, R & D BOTHELLDobmeier  EricBothellFBB2 LLCNEW YORKFBB3 LLCNEW YORKBaker  FelixBothellH PERRY  FELLChairman BOTHELLBerger  FranklinBothellJONATHAN  GALLEN10% Owner NEW YORKDAVID W  GRYSKADirector SOUTH SAN FRANCISCODAVID W  GRYSKADirector BOTHELLH&Q Employee Venture Fund 2000, L.P.NEW YORKH&Q Employee Venture Fund 2000, L.P.NEW YORKH&Q Employee Venture Fund 2000, L.P.NEW YORKH&Q Holdings, Inc.10% Owner NEW YORKH&Q Holdings, Inc.10% Owner NEW YORKKARL ERIK  HELLSTROMDirector SEATTLEVAUGHN B  HIMESChief Technical Officer SEATTLEVAUGHN B  HIMESEVP, Tech. Ops. & Proc. Sci. BOTHELLDaniel Floyd  Hoth JRDirector BOTHELLJ P MORGAN CHASE & CONEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS A LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS A LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS A LPJ P MORGAN PARTNERS GLOBAL INVESTORS A LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS A LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS A LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS A LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LPNEW YORKJ P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LPNEW YORKMcLaughlin  JohnBothellMORGAN CHASE BANK  JPNEW YORKJP MORGAN PARTNERS BHCA LP10% Owner NEW YORKJP MORGAN PARTNERS BHCA LP10% Owner NEW YORKJP MORGAN PARTNERS BHCA LP10% Owner NEW YORKJP MORGAN PARTNERS BHCA LP10% Owner NEW YORKJP MORGAN PARTNERS BHCA LP10% Owner NEW YORKJP MORGAN PARTNERS BHCA LP10% Owner NEW YORKJP MORGAN PARTNERS BHCA LP10% Owner NEW YORKJP MORGAN PARTNERS BHCA LP10% Owner NEW YORKJP MORGAN PARTNERS GLOBAL INVESTORS LPNEW YORKJP MORGAN PARTNERS GLOBAL INVESTORS LPNEW YORKJP MORGAN PARTNERS GLOBAL INVESTORS LPNEW YORKJP MORGAN PARTNERS GLOBAL INVESTORS LPJP MORGAN PARTNERS GLOBAL INVESTORS LPNEW YORKJP MORGAN PARTNERS GLOBAL INVESTORS LPNEW YORKJP MORGAN PARTNERS GLOBAL INVESTORS LPNEW YORKJP MORGAN PARTNERS GLOBAL INVESTORS LPNEW YORKJP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L PNEW YORKJP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L PNEW YORKJP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L PNEW YORKJP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L PNEW YORKMORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP  JPNEW YORKMORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP  JPNEW YORKMORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP  JPNEW YORKMORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP  JPNEW YORKJPMP CAPITAL CORPNEW YORKJPMP CAPITAL CORPNEW YORKJPMP CAPITAL CORPNEW YORKJPMP CAPITAL CORPNEW YORKJPMP CAPITAL CORPNEW YORKJPMP CAPITAL CORPNEW YORKJPMP CAPITAL LLCNEW YORKJPMP GLOBAL FUND BILL BARRETT SELLDOWN LPNEW YORKJPMP GLOBAL FUND BILL BARRETT SELLDOWN LPNEW YORKJPMP GLOBAL INVESTORS L PNEW YORKJPMP GLOBAL INVESTORS L PNEW YORKJPMP GLOBAL INVESTORS L PNEW YORKJPMP GLOBAL INVESTORS L PNEW YORKJPMP GLOBAL INVESTORS L PNEW YORKJPMP MASTER FUND MANAGER L PNEW YORKJPMP MASTER FUND MANAGER L PNEW YORKJPMP MASTER FUND MANAGER L PNEW YORKJPMP MASTER FUND MANAGER L PNEW YORKJPMP MASTER FUND MANAGER L PNEW YORKJPMP MASTER FUND MANAGER L PNEW YORKJPMP MASTER FUND MANAGER L PNEW YORKMARC E  LIPPMANDirector MARC E  LIPPMANDirector ANN ARBORMARC E  LIPPMANDirector ANN ARBORMARC E  LIPPMANDirector BOTHELLJEAN I  LIUGC/EVP, Leg Affairs CUPERTINOJEAN I  LIUEVP, Legal Affairs & GC BOTHELLLippman  MarkBothellMICHAEL  MCDONALDChief Medical Officer BOTHELLJOHN PETER  MCLAUGHLINDirector SOUTH SAN FRANCISCOJOHN PETER  MCLAUGHLINDirector BOTHELLJOHN PETER  MCLAUGHLINBOTHELLRosenberg  MorrisBothellJohn A  OrwinDirector SAN MATEOJohn A  OrwinDirector BOTHELLMICHAEL  POWELLMICHAEL  POWELLDirector SAN FRANCISCOThomas C  ReynoldsChief Medical Officer BOTHELLMORRIS  ROSENBERGSVP, Development WOODINVILLEMORRIS  ROSENBERGEVP, Process Sciences BOTHELLBRUCE J.  SEELEYEVP, Commerical BOTHELLPETER  SENTERVice President, Chemistry BOTHELLCLAY B  SIEGALLPresident and CEO BOTHELLCLAY B  SIEGALLPresident & CEO SE BOTHELLNancy A  SimonianDirector WOBURNNancy A  SimonianDirector BOTHELLTODD E  SIMPSONChief Financial Officer SEATTLETODD E  SIMPSONChief Financial Officer BOTHELLAMY  SINGSr. Director Medical Affairs BOTHELLAMY  SINGSr. Director Medical Affairs BOTHELLDOUGLAS  SOUTHERNDOUGLAS  SOUTHERNDirector BOTHELLAkkaraju  SrinivasBothellReynolds  ThomasBothellSimpson  ToddBothellPamela A  TrailSmithChief Scientific Officer BOTHELLDANIEL G  WELCHDirector BRISBANEDANIEL G  WELCHDirector BOTHELLDOUGLAS E  WILLIAMSCSO, EVP R&D BOTHELLPersons related to 14159, L.P. - ACADIA PHARMACEUTICALS INCNamePositionCity667, L.P.NEW YORKThomas H  AasenVP, CFO, Sec. Treas. SAN DIEGOThomas H  AasenVP, CFO, Sec. Treas. SAN DIEGOThomas H  AasenExec. VP, CFO & CBO SAN DIEGOThomas H  AasenEXEC VP, CFO AND CBO SAN DIEGOThomas H  AasenEXEC VP, CFO AND CBO SAN DIEGOGlenn  BaityEVP AND GC SAN DIEGOGlenn  BaityVP AND GC SAN DIEGOGlenn  BaityEVP AND GC SAN DIEGOBaker Bros. Advisors (GP) LLCNEW YORKBAKER BROS ADVISORS LLCDirector NEW YORKBAKER BROS ADVISORS LLCDirector NEW YORKBAKER BROS. ADVISORS LPDirector NEW YORKBaker Brothers Life Sciences LPNEW YORKFELIX  BAKERFELIX  BAKERDirector NEW YORKJULIAN  BAKERJULIAN  BAKERNEW YORKJEFFREY T  BARNESBOSTONJEFFREY T  BARNESBOSTONStephen R  BiggarLEXINGTONGordon M  BinderDirector LOS ANGELESGordon M  BinderDirector SAN DIEGOGordon M  BinderDirector SAN DIEGOGordon M  BinderDirector SAN DIEGOMICHAEL T  BORER SAN DIEGOMICHAEL T  BORERDirector SAN DIEGOMICHAEL T  BORERDirector SAN DIEGOMICHAEL T  BORER SAN DIEGOMICHAEL T  BORER SAN DIEGOMark R  BrannPres., Chief Scientific Off. SAN DIEGOMark R  BrannPresident, Chf. Sci. Officer SAN DIEGOMark R  BrannPresident & CSO SAN DIEGOMark R  BrannPresident, CSO SAN DIEGOMark R  BrannPresident & CSO SAN DIEGOLaura  Brege EMERYVILLELaura  BregeDirector SAN DIEGOLaura  Brege SAN DIEGOLaura  Brege SAN DIEGOMARK  CARTHYBOSTONMARK  CARTHYBOSTONJames M  Daly WILMINGTONRobert E  DavisSAN DIEGORobert E  DavisExec. VP, Drug Discovery SAN DIEGOSTEPHEN  DAVISPRESIDENT AND CEO BRANFORDSTEPHEN  DAVISSAN DIEGOJONATHAN  FLEMINGBOSTONJONATHAN  FLEMINGBOSTONBAITY  GLENNSAN DIEGOCARL L  GORDONDirector NEW YORKMARY ANN  GRAY PALO ALTOMARY ANN  GRAY SAN DIEGOMARY ANN  GRAY SAN DIEGOMARY ANN  GRAYDirector SAN DIEGOMARY ANN  GRAYDirector SAN DIEGOMARY ANN  GRAYDirector SAN DIEGOUli  HacksellCEO SAN DIEGOUli  HacksellChief Executive Officer SAN DIEGOUli  HacksellCEO SAN DIEGOUli  HacksellCEO SAN DIEGOUli  HacksellCEO SAN DIEGOEDMUND  HARRIGAN SAN DIEGOLeslie L  IversenDirector OXFORD OX1 3QT, UNITED KINGDOMLeslie L  IversenDirector SAN DIEGOLeslie L  IversenDirector SAN DIEGOLeslie L  Iversen SAN DIEGOLeslie L  Iversen SAN DIEGOJohn Joseph  KaiserVP, Strat. Mrkting & Com. Dev. SAN DIEGOLESTER J PH D  KAPLAN IRVINELESTER J PH D  KAPLANLAGUNA BEACHLESTER J PH D  KAPLANDirector LAGUNA BEACHLESTER J PH D  KAPLANDirector SAN DIEGOLESTER J PH D  KAPLANDirector SAN DIEGOLESTER J PH D  KAPLANDirector SAN DIEGOLESTER J PH D  KAPLAN SAN DIEGOLESTER J PH D  KAPLAN SAN DIEGOBREGE  LAURASAN DIEGOIVERSEN  LESLIESAN DIEGOKAPLAN  LESTERSAN DIEGOBrian  LundstromSr. VP, Bus. Development SAN DIEGOBrian  LundstromSr. VP. Business Development SAN DIEGOBrian  LundstromSr. V.P., Bus. Devt. SAN DIEGOMICHAEL  LYTTONBOSTONMICHAEL  LYTTONBOSTONANN  GRAY  MARYSAN DIEGOBORER  MICHAELSAN DIEGORoger  MillsEVP, DEVELOPMENT AND CMO SAN DIEGORoger  MillsEVP, DEVELOPMENT AND CMO SAN DIEGORoger  MillsEVP, DEVELOPMENT AND CMO SAN DIEGOTerrence O  MooreEVP, CHIEF COMMERCIAL OFFICER POINT RICHMONDTerrence O  MooreEVP, CHIEF COMMERCIAL OFFICER SAN DIEGOTerrence O  MooreEVP, CHIEF COMMERCIAL OFFICER SAN DIEGOMRNA FUND  II LPBOSTONMRNA FUND  II LPBOSTONINTERNATIONAL PLC  NOMURALONDONNomura Phase4 Ventures GP LTDLONDONNomura Phase4 Ventures LPLONDONNomura Phase4 Ventures LTDLONDONOBP MANAGEMENT IV LPBOSTONOBP MANAGEMENT IV LPBOSTONOXFORD BIOSCIENCE PARTNERS IV LP10% Owner BOSTONOXFORD BIOSCIENCE PARTNERS IV LP10% Owner BOSTONTorsten  RasmussenDirector DK-7182 BREDSTEN, DENMARKTorsten  RasmussenDirector SAN DIEGOTorsten  RasmussenDirector SAN DIEGOTorsten  RasmussenDirector SAN DIEGOTorsten  Rasmussen SAN DIEGOTorsten  Rasmussen SAN DIEGODouglas E  RichardsSAN DIEGOMILLS  ROGERSAN DIEGODANIEL B  SOLAND EMERYVILLESrdjan R.  StankovicEVP BRANFORDAASEN  THOMASSAN DIEGOBo-Ragnar  TolfDK-2600 GLOSTRUP, DENMARKBo-Ragnar  TolfVP Chm/Mng Dir ACADIA Phrm A/S SAN DIEGOBo-Ragnar  TolfVP/Mg. Dir. ACADIA Pharma AB SAN DIEGORASMUSSEN  TORSTENSAN DIEGOHACKSELL  ULISAN DIEGOOsch Martien  van1000 EA AMSTERDAM, NETHERLANDSOsch Martien  vanDirector 1000 EA AMSTERDAM, NETHERLANDSOsch Martien  vanDirector AMSTERDAM, THE NETHERLANDSOsch Martien  vanDirector SAN DIEGOALAN G  WALTONDirector WESTPORTALAN G  WALTONBOSTONWilliam McDowall  Wells MISSISSAUGAWilliam McDowall  Wells SAN DIEGOWilliam McDowall  Wells SAN DIEGOWilliam McDowall  Wells SAN DIEGOWELLS  WILLIAMSAN DIEGOMICHAEL J.  YANGEVP AND CCO SAN DIEGOTODD S.  YOUNGEVP AND CFO SAN DIEGOPersons related to 14159, L.P. - GENOMIC HEALTH INCNamePositionCity14159 capital (GP), LLCDirector NEW YORK14159 capital (GP), LLCDirector NEW YORK14159 capital (GP), LLCDirector NEW YORK667, L.P.NEW YORKBRIAN G  ATWOODMENLO PARKBaker Biotech Capital (GP), LLCDirector NEW YORKBaker Biotech Capital (GP), LLCDirector NEW YORKBaker Biotech Capital (GP), LLC10% Owner NEW YORKBaker Biotech Capital (GP), LLCDirector NEW YORKBaker Biotech Capital II (GP), LLC10% Owner NEW YORKBaker Biotech Capital II (Z) (GP), LLC10% Owner NEW YORKBaker Biotech Capital III (GP), LLC10% Owner NEW YORKBaker Biotech Capital III (Z) (GP), LLC10% Owner NEW YORKBaker Bros. Advisors (GP) LLCNEW YORKBAKER BROS ADVISORS LLCDirector NEW YORKBAKER BROS ADVISORS LLCNEW YORKBAKER BROS. ADVISORS LPNEW YORKBaker Bros. Capital (GP), LLC10% Owner NEW YORKBaker Bros. Capital (GP), LLCDirector NEW YORKBaker Bros. Capital (GP), LLCDirector NEW YORKBaker Bros. Investments II, L.P.NEW YORKBaker Bros. Investments, L.P.NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences Capital (GP), LLCDirector NEW YORKBaker Brothers Life Sciences LPNEW YORKFELIX  BAKERDirector FELIX  BAKERDirector NEW YORKFELIX  BAKERNEW YORKFELIX  BAKERNEW YORKFELIX  BAKERDirector NEW YORKJoffre  BakerChief Scientific Officer REDWOOD CITYJULIAN  BAKERJULIAN  BAKERDirector NEW YORKJULIAN  BAKERNEW YORKJULIAN  BAKERDirector NEW YORKJULIAN  BAKERDirector NEW YORKJULIAN  BAKERDirector NEW YORKJULIAN  BAKERDirector NEW YORKJULIAN  BAKERNEW YORKBaker / Tisch Capital (GP), LLC10% Owner NEW YORKBaker / Tisch Capital (GP), LLCDirector NEW YORKBaker/Tisch Investments, LPNEW YORKBROOK H  BYERSDirector MENLO PARKBROOK H  BYERSDirector MENLO PARKBROOK H  BYERSDirector MENLO PARKBROOK H  BYERSDirector MENLO PARKFred E  CohenDirector SAN FRANCISCOFred E  CohenDirector SAN FRANCISCOFred E  CohenDirector SAN FRANCISCOFred E  CohenDirector SAN FRANCISCOG Bradley  ColeCOO REDWOOD CITYSAMUEL D  COLELLADirector MENLO PARKSAMUEL D  COLELLADirector MENLO PARKSAMUEL D  COLELLADirector MENLO PARKSAMUEL D  COLELLADirector MENLO PARKAssociates  FBBNEW YORKPhillip G.  FebboChief Medical Officer REDWOOD CITYHENRY J  FUCHSDirector PALO ALTOHENRY J  FUCHSDirector NOVATOMichael D  GoldbergDirector MENLO PARKMichael D  GoldbergDirector MENLO PARKMichael D  GoldbergDirector MENLO PARKMichael D  GoldbergDirector MENLO PARKGINGER L  GRAHAMDirector GINGER L  GRAHAMDirector REDWOOD CITYGINGER L  GRAHAMDirector BOULDERKATHY L  HIBBSSVP & General Counsel REDWOOD CITYROSS A MD  JAFFEMENLO PARKKLEINER PERKINS CAUFIELD & BYERS X A LP10% Owner MENLO PARKKLEINER PERKINS CAUFIELD & BYERS X B LP10% Owner MENLO PARKKPCB X ASSOCIATES LLC10% Owner MENLO PARKLaura  LeberChief Communication Officer REDWOOD CITYWILLIAM J PHD  LINKMENLO PARKRANDALL S  LIVINGSTONDirector STANFORDRANDALL S  LIVINGSTONDirector STANFORDRANDALL S  LIVINGSTONDirector STANFORDBARBARA N  LUBASHMENLO PARKKim  McEachronChief People Officer REDWOOD CITYDONALD B  MILDERMENLO PARKWOODROW A  MYERS JRDirector REDWOOD CITYWOODROW A  MYERS JRDirector THOUSAND OAKSWOODROW A  MYERS JRDirector WOODLAND HILLSWOODROW A  MYERS JRDirector INDIANAPOLISGeoffrey M.  ParkerDirector CARLSBADFrederic  PlaChief Bus & Prod Dev Officer REDWOOD CITYKimberly J  PopovitsPresident and CEO REDWOOD CITYKimberly J  PopovitsPresident and CEO REDWOOD CITYJason W.  RadfordChief Legal Officer REDWOOD CITYREBECCA B  ROBERTSON10% Owner MENLO PARKDean L  SchornoCFO REDWOOD CITYRandal W  ScottChief Executive Officer REDWOOD CITYRandal W  ScottCEO, InVitae Corporation* REDWOOD CITYSteven  ShakChief Scientific Officer REDWOOD CITYTarrant Advisors, IncSAN FRANSICOTarrant Advisors, Inc10% Owner SAN FRANCISCOJames J  VaughnChief Commercial Officer REDWOOD CITYVERSANT AFFILIATES FUND I-A LPMENLO PARKVERSANT AFFILIATES FUND I-B LPMENLO PARKVERSANT SIDE FUND I LPMENLO PARKVERSANT VENTURE CAPITAL I LP10% Owner MENLO PARKVERSANT VENTURES I LLCMENLO PARKPersons related to 14159, L.P. - BeiGene, Ltd.NamePositionCity667, L.P.NEW YORKBaker Bros. Advisors (GP) LLCNEW YORKBAKER BROS ADVISORS LLCDirector NEW YORKBaker Brothers Life Sciences LPNEW YORKFELIX  BAKERJULIAN  BAKERCB Biotech Investment Ltd10% Owner ROAD TOWN, TORTOLATimothy Yung-Cheng  ChenDirector MILPITASCITIC PE Associates, L.P.ROAD TOWN, TORTOLACITIC PE Funds LtdROAD TOWN, TORTOLACPEChina Fund, L.P.ROAD TOWN, TORTOLADonald W.  GlazerDirector CAMANA BAY, GRAND CAYMANMICHAEL  GOLLERNEW YORKHillhouse Capital Management, Ltd.10% Owner GRAND CAYMANJane  HuangCMO, Hematology CAMANA BAY, GRAND CAYMANRANJEEV  KRISHANANEW YORKJi  LiEVP and Gl. Head of Bus. Dev. CAMANA BAY, GRAND CAYMANHoward  LiangCFO & CSO CAMANA BAY, GRAND CAYMANThomas  MalleyDirector DENVERMerck & Co., Inc.10% Owner KENILWORTHMerck Sharp & Dohme Corp.WHITEHOUSE STATIONMerck Sharp & Dohme Research GmbHLUCERNE 6JOHN  OYLERChief Executive Officer SAN DIEGOAmy C.  PetersonCMO, Immuno-oncology CAMANA BAY, GRAND CAYMANKe  TangDirector CAMANA BAY, GRAND CAYMANXiaodong  WangDirector CAMANA BAY, GRAND CAYMANWendy Xiaojun  YanSr. VP, Head of Reg. Affairs CAMANA BAY, GRAND CAYMANJianxin  YangSr. VP, Head of Clinical Dev. CAMANA BAY, GRAND CAYMANQingqing  YiDirector GRAND CAYMANRuiRong  YuanChief Medical Officer CAMANA BAY












 






      14159, L.p. - Insider Monkey                          Companies 0 See All     Hedge Funds 0 See All    Insiders 0 See All    Institutional Investors 0 See All   Click here to see all  results for  Sorry, no results has been found matching your query.                   Adblocker Detected    Dear Valued Visitor, We have noticed that you are using an ad blocker software.
    Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. To view this article, you can disable your ad blocker and refresh this page or simply login. We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.       Home > Insider Trading > 14159, L.p.
				> Profile    14159, L.p.    Profile Insider Purchases Insider Sales News      Affiliations  Director at Idera Pharmaceuticals Inc. (IDRA), 2017-07-06 Large Shareholder, Director at Genomic Health Inc (GHDX), 2017-07-05 Large Shareholder, Director at Incyte Corp (INCY), 2017-07-05 Large Shareholder, Director at Acadia Pharmaceuticals Inc (ACAD), 2017-06-14 Large Shareholder, Director at Beigene Ltd. (BGNE), 2017-04-21 Other at Xoma Corp (XOMA), 2015-07-23 Other at Synageva Biopharma Corp (GEVA), 2015-06-23 Large Shareholder, Director at Seattle Genetics Inc (SGEN), 2014-12-11 Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2013-08-02     Insider Trading: Purchases See All      Company Symbol Price Amount Relationship Remaning Holdings Date Form 4    Acadia Pharmaceuticals Inc ACAD $29.00 1,801,161 Large Shareholder, Director 20,278,008 2016-01-07 Filing   Acadia Pharmaceuticals Inc ACAD $29.00 785,045 Large Shareholder, Director 2,337,100 2016-01-07 Filing                Home Hedge Funds Markets Blog Authors About Us Contact Us Privacy Policy Terms of Use Site Map  All text and design is copyright ©2016 Koala Guide LLC. All rights reserved.             


Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft










      
  
    Buy Hand Conduit Benders and Handles | Zoro.com
  

    
LAWN AND OUTDOOR SALE•20% OFF 5 CATEGORIES•Enter Code: LAWNGEAR•JULY 25-31•SEE DETAILS AND CATEGORIESEnter Search TermWelcomeMy AccountSign OutSign In/Register...Cart
          
            Shop Categories
          
        
                Safety & SecuritySafety & Security
                      Fall Protection, Facility & Traffic  Safety Equipment 
                    
                      Gloves, Eyewear, Ear Protection, Masks & Clothing
                    
                      Padlocks, Lockout/Tagout & Security Equipment
                    
                      Signs & Labels
                    
                      Test Instruments & Gauges
                    
                Tools & MachiningTools & Machining
                      Abrasives & Polishers
                    
                      Cutting, Holemaking & Shaping Tools
                    
                      Hand Tools
                    
                      Knobs, Handles, Workholding & Machine Tool Accessories
                    
                      Power Tools and Accessories
                    
                      Raw Materials
                    
                Plumbing & HVACPlumbing & HVAC
                      Fans & HVAC Equipment
                    
                      Pipes, Valves & Fittings
                    
                      Toilets, Sinks, Faucets & Plumbing Supplies
                    
                Material HandlingMaterial Handling
                      Carts, Trucks & Casters
                    
                      Drum & Dock Equipment
                    
                      Material Handling Equipment (Pulling, Lifting, Lowering, Conveying)
                    
                      Storage, Shelving, Ladders & Lifts
                    
                Electrical & LightingElectrical & Lighting
                      Electrical Supplies & Generators
                    
                      Lighting, Flashlights & Batteries
                    
                Adhesives, Fasteners, & WeldingAdhesives, Fasteners, & Welding
                      Adhesives & Sealants
                    
                      Fasteners
                    
                      Tapes (Electrical, Duct, Painters)
                    
                      Welding & Soldering Equipment & Supplies
                    
                Janitorial & Grounds MaintenanceJanitorial & Grounds Maintenance
                      Door and Cabinet Hinges & Hardware
                    
                      Grounds Maintenance & Outdoor Equipment
                    
                      Janitorial & Cleaning Supplies
                    
                      Paint, Coatings & Supplies
                    
                Power Transmission & PneumaticsPower Transmission & Pneumatics
                      Auto & Truck Maintenance
                    
                      Bearings, V-belts & Power Transmission Equipment
                    
                      Compressors, Air Tanks & Pneumatic Tools 
                    
                      Fluids & Lubricants
                    
                      Hydraulic Cylinders & Equipment
                    
                      Motors
                    
                Office & ShippingOffice & Shipping
                      Office Supplies, Furniture & Breakroom Supplies
                    
                      Shipping & Packing Supplies
                    About UsPayment OptionsResourcesPromo CodesContact UsShop CategoriesAdhesives, Fasteners, & WeldingElectrical & LightingJanitorial & Grounds MaintenanceMaterial HandlingOffice & ShippingPlumbing & HVACPower Transmission & PneumaticsSafety & SecurityTools & MachiningAbout UsPayment OptionsResourcesPromo CodesContact UsMy AccountSign OutSign In/RegisterHomeHand ToolsBendersHand Conduit Benders and Handles
            Browse Categories
            Filter by
                Brands
                
                Price
                
          See 4 More Filters
        
    featured
  Offset Bender For 3/4 EmtGREENLEE|Zoro #: G0579078 |
    Mfr #: 14159
  Item: Offset Bender For 3/4 Emt
    View Full Product Details
    
  
    
      This item ships free. DetailsStandard ground shipping$373.78/eaqtyAdd to CartShowing 
      1 - 30 of 68
      results
    
  Sort by: RelevancePrice: Low to High
        Price: High to Low
        Product Name: A-Z
        Product Name: Z-A
        Brand: A-Z
        Brand: Z-A
        Previous123Next123Shipping InformationA $5.00 shipping and handling fee is charged on orders totaling less than
        $50.00
        before tax and shipped to one address within the continental United States.No shipping and handling is charged to customers for standard ground delivery on orders of
        $50.00
        or more before tax.Shipping Policy Exceptions:Not all products qualify for the above Shipping Policy. Additionally, standard shipping rates will apply for all orders to Alaska and Hawaii.Any charges incurred for hazardous materials or other special handling by the carrier must be paid by the customer.Fuel surcharges may be applied.Zoro only accepts orders for shipments within the continental US, Alaska and Hawaii.Orders to international destinations will not be processed.Zoro does not ship to PO Box addresses.UPS is our primary parcel carrier and we use a variety of carriers for LTL shipments.Expedited Shipping Rules:To qualify for expedited shipping Zoro must receive your order before 3:00PM CST Monday–Friday; all orders must weigh less than 150 lbs, and not contain any hazardous materials.Expedited orders only ship on business days; any orders placed on Satudays/Sundays/Holidays will be processed on the next business day.If you have any questions please call our customer service department at 855‑BUY-ZORO (855-289-9676).In Stock
  Item ships from Zoro warehouses and will ship within 1 business day. Standard delivery time is 3-5 business days.
  You will be provided tracking via email as soon as your order ships.
Orders that qualify for expedited shipping must be placed by 3pm CST to ship same day.Limited Stock
  This item has low stock in our warehouses and your order will ship based on availability. If an item cannot be fulfilled immediately it will be ordered from our manufacturer.
Orders that qualify for expedited shipping must be placed by 3pm CST to ship same day.Backordered
  Item is not currently in stock and will be ordered from manufacturer to fulfill your order.
  As soon as your order ships you will receive tracking information via email.
Drop ship
  Item will ship from manufacturer within the lead time specified on this page.


      Zoro.com: Industrial Supplies, Tools, MRO Products & More
    
LAWN AND OUTDOOR SALE•20% OFF 5 CATEGORIES•Enter Code: LAWNGEAR•JULY 25-31•SEE DETAILS AND CATEGORIESEnter Search TermWelcomeMy AccountSign OutSign In/Register...Cart
          
            Shop Categories
          
        
                Safety & SecuritySafety & Security
                      Fall Protection, Facility & Traffic  Safety Equipment 
                    
                      Gloves, Eyewear, Ear Protection, Masks & Clothing
                    
                      Padlocks, Lockout/Tagout & Security Equipment
                    
                      Signs & Labels
                    
                      Test Instruments & Gauges
                    
                Tools & MachiningTools & Machining
                      Abrasives & Polishers
                    
                      Cutting, Holemaking & Shaping Tools
                    
                      Hand Tools
                    
                      Knobs, Handles, Workholding & Machine Tool Accessories
                    
                      Power Tools and Accessories
                    
                      Raw Materials
                    
                Plumbing & HVACPlumbing & HVAC
                      Fans & HVAC Equipment
                    
                      Pipes, Valves & Fittings
                    
                      Toilets, Sinks, Faucets & Plumbing Supplies
                    
                Material HandlingMaterial Handling
                      Carts, Trucks & Casters
                    
                      Drum & Dock Equipment
                    
                      Material Handling Equipment (Pulling, Lifting, Lowering, Conveying)
                    
                      Storage, Shelving, Ladders & Lifts
                    
                Electrical & LightingElectrical & Lighting
                      Electrical Supplies & Generators
                    
                      Lighting, Flashlights & Batteries
                    
                Adhesives, Fasteners, & WeldingAdhesives, Fasteners, & Welding
                      Adhesives & Sealants
                    
                      Fasteners
                    
                      Tapes (Electrical, Duct, Painters)
                    
                      Welding & Soldering Equipment & Supplies
                    
                Janitorial & Grounds MaintenanceJanitorial & Grounds Maintenance
                      Door and Cabinet Hinges & Hardware
                    
                      Grounds Maintenance & Outdoor Equipment
                    
                      Janitorial & Cleaning Supplies
                    
                      Paint, Coatings & Supplies
                    
                Power Transmission & PneumaticsPower Transmission & Pneumatics
                      Auto & Truck Maintenance
                    
                      Bearings, V-belts & Power Transmission Equipment
                    
                      Compressors, Air Tanks & Pneumatic Tools 
                    
                      Fluids & Lubricants
                    
                      Hydraulic Cylinders & Equipment
                    
                      Motors
                    
                Office & ShippingOffice & Shipping
                      Office Supplies, Furniture & Breakroom Supplies
                    
                      Shipping & Packing Supplies
                    About UsPayment OptionsResourcesPromo CodesContact UsShop CategoriesAdhesives, Fasteners, & WeldingElectrical & LightingJanitorial & Grounds MaintenanceMaterial HandlingOffice & ShippingPlumbing & HVACPower Transmission & PneumaticsSafety & SecurityTools & MachiningAbout UsPayment OptionsResourcesPromo CodesContact UsMy AccountSign OutSign In/RegisterSafety & SecurityTools & MachiningPlumbing & HVACMaterial HandlingElectrical & LightingAdhesives, Fasteners & WeldingJanitorial & Grounds MaintenancePower Transmission & PneumaticsOffice & ShippingLearn more about Zoro

      Contact Us
    
LAWN AND OUTDOOR SALE•20% OFF 5 CATEGORIES•Enter Code: LAWNGEAR•JULY 25-31•SEE DETAILS AND CATEGORIESEnter Search TermWelcomeMy AccountSign OutSign In/Register...Cart
          
            Shop Categories
          
        
                Safety & SecuritySafety & Security
                      Fall Protection, Facility & Traffic  Safety Equipment 
                    
                      Gloves, Eyewear, Ear Protection, Masks & Clothing
                    
                      Padlocks, Lockout/Tagout & Security Equipment
                    
                      Signs & Labels
                    
                      Test Instruments & Gauges
                    
                Tools & MachiningTools & Machining
                      Abrasives & Polishers
                    
                      Cutting, Holemaking & Shaping Tools
                    
                      Hand Tools
                    
                      Knobs, Handles, Workholding & Machine Tool Accessories
                    
                      Power Tools and Accessories
                    
                      Raw Materials
                    
                Plumbing & HVACPlumbing & HVAC
                      Fans & HVAC Equipment
                    
                      Pipes, Valves & Fittings
                    
                      Toilets, Sinks, Faucets & Plumbing Supplies
                    
                Material HandlingMaterial Handling
                      Carts, Trucks & Casters
                    
                      Drum & Dock Equipment
                    
                      Material Handling Equipment (Pulling, Lifting, Lowering, Conveying)
                    
                      Storage, Shelving, Ladders & Lifts
                    
                Electrical & LightingElectrical & Lighting
                      Electrical Supplies & Generators
                    
                      Lighting, Flashlights & Batteries
                    
                Adhesives, Fasteners, & WeldingAdhesives, Fasteners, & Welding
                      Adhesives & Sealants
                    
                      Fasteners
                    
                      Tapes (Electrical, Duct, Painters)
                    
                      Welding & Soldering Equipment & Supplies
                    
                Janitorial & Grounds MaintenanceJanitorial & Grounds Maintenance
                      Door and Cabinet Hinges & Hardware
                    
                      Grounds Maintenance & Outdoor Equipment
                    
                      Janitorial & Cleaning Supplies
                    
                      Paint, Coatings & Supplies
                    
                Power Transmission & PneumaticsPower Transmission & Pneumatics
                      Auto & Truck Maintenance
                    
                      Bearings, V-belts & Power Transmission Equipment
                    
                      Compressors, Air Tanks & Pneumatic Tools 
                    
                      Fluids & Lubricants
                    
                      Hydraulic Cylinders & Equipment
                    
                      Motors
                    
                Office & ShippingOffice & Shipping
                      Office Supplies, Furniture & Breakroom Supplies
                    
                      Shipping & Packing Supplies
                    About UsPayment OptionsResourcesPromo CodesContact UsShop CategoriesAdhesives, Fasteners, & WeldingElectrical & LightingJanitorial & Grounds MaintenanceMaterial HandlingOffice & ShippingPlumbing & HVACPower Transmission & PneumaticsSafety & SecurityTools & MachiningAbout UsPayment OptionsResourcesPromo CodesContact UsMy AccountSign OutSign In/RegisterContact usWe’re happy to answer your questions. We respond to most inquiries within 24 hours.Contact usWe’re happy to answer your questions. We respond to most inquiries within 24 hours.We’re not satisfied until you areMost of our business happens right here on Zoro.com. But, we know sometimes you just need to talk to a real person. Whether you want to call us or email us, our customer service staff is available Monday through Friday from 6 a.m. to 9 p.m. (CST) and Saturdays from 7 a.m. to 5 p.m. (CST).Si necesita ayuda en español, por favor, comuníquese con nosotros por teléfono. Gracias.Phone 855.BUY.ZORO (855.289.9676)Fax 855.FAX.ZORO (855.329.9676)
